This document provides an overview of mHealth adoption barriers according to human behaviour as seen by healthcare professionals and patients. It discusses the scope of mHealth including remote care services and technologies. While patients and healthcare professionals see benefits to using mobile technologies to improve care, concerns around reliability, costs of implementation and ability of patients to use technologies are barriers to widespread adoption. The document aims to better understand these barriers to generate positive change.
The advent of personalized medicine is greatly enhanced by consumer level DNA reports. This is a sample DNA weight loss report that we use with our 3D Fat Loss Program. www.3dFatLoss.com, which is being rolled out nationally with medical professionals in multiple disciplines.
The advent of personalized medicine is greatly enhanced by consumer level DNA reports. This is a sample DNA weight loss report that we use with our 3D Fat Loss Program. www.3dFatLoss.com, which is being rolled out nationally with medical professionals in multiple disciplines.
Talking about topics like gender, race, sexual orientation, and class can raise anxiety for many people, and yet we must have the conversation in our schools and our lives in order to be more inclusive and change the world for the better. What are the fears and common pitfalls that keep us from broaching courageous conversations? Gain practical skills for responding to hurtful experiences and facilitating courageous conversations.
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...Enrike G. Argandoña
Microvascular environment plays a fundamental role in the adaptive response to increases in activity, involving an increase in energy demand. To puntual increases in demand, the response is effected by changes in local flow, but if demand remains high, angiogenic process is triggered through the formation of new capillaries from preexisting vessels. The trigger factor of angiogenesis is local neuronal hypoxia as result of increased activity, mediated by angioglioneurins whose main exponent is VEGF. There are situations in which hypoxia is not from an increased activity, but a decrease in available oxygen, as occurs in the altitude exposure.
Our goal is to study the changes underlying microvascular acute adaptation to moderate altitude and the possible effects of physical exercise.
Wistar rats bred to 400 m (P47) and transported to a height of 2800m on a journey of 35 minutes. We used the following cohorts of 7 rats each: a group was housed indoors in standard laboratory conditions, another group had free access to
an exercise wheel. As controls, we used animals born at 400m. After 48 h, animals were sacrificed and after neuropathological examination by conventional histology, capillary density was quantified using computer assisted stereology on thick sections processed using Butyryl Cholinesterase Histochemistry (Argandoña, Brain Res, 1996).
Three cortical areas were quantified, motor, somatosensory and visual cortices.
Rats with free access to exercise wheel showed higher vascular density in response to hypoxia, while the rest showed similar values. Differences were significant in all three areas, being highest in the motor cortex.
The acute adaptation to moderate altitude is an increasingly relevant issue given the increase in displacements at moderate or high altitudes, with serious consequences such as Acute Mountain Sickness, which in its most severe degree leads to
Brain edema. Our results show that exercise can play a protective role through adaptive angiogenesis.
Christian Bason comes to MaRS for the first event of the Inspiring Action for Social Impact Series - a national program that presents international thought leaders, applied learning and practical strategies for social innovation in Canada. The Inspiring Action for Social Impact Series is presented by Social Innovation Generation (SiG), PLAN Institute and the Public Policy Forum. It will tour throughout Canada in 2011.
Talking about topics like gender, race, sexual orientation, and class can raise anxiety for many people, and yet we must have the conversation in our schools and our lives in order to be more inclusive and change the world for the better. What are the fears and common pitfalls that keep us from broaching courageous conversations? Gain practical skills for responding to hurtful experiences and facilitating courageous conversations.
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...Enrike G. Argandoña
Microvascular environment plays a fundamental role in the adaptive response to increases in activity, involving an increase in energy demand. To puntual increases in demand, the response is effected by changes in local flow, but if demand remains high, angiogenic process is triggered through the formation of new capillaries from preexisting vessels. The trigger factor of angiogenesis is local neuronal hypoxia as result of increased activity, mediated by angioglioneurins whose main exponent is VEGF. There are situations in which hypoxia is not from an increased activity, but a decrease in available oxygen, as occurs in the altitude exposure.
Our goal is to study the changes underlying microvascular acute adaptation to moderate altitude and the possible effects of physical exercise.
Wistar rats bred to 400 m (P47) and transported to a height of 2800m on a journey of 35 minutes. We used the following cohorts of 7 rats each: a group was housed indoors in standard laboratory conditions, another group had free access to
an exercise wheel. As controls, we used animals born at 400m. After 48 h, animals were sacrificed and after neuropathological examination by conventional histology, capillary density was quantified using computer assisted stereology on thick sections processed using Butyryl Cholinesterase Histochemistry (Argandoña, Brain Res, 1996).
Three cortical areas were quantified, motor, somatosensory and visual cortices.
Rats with free access to exercise wheel showed higher vascular density in response to hypoxia, while the rest showed similar values. Differences were significant in all three areas, being highest in the motor cortex.
The acute adaptation to moderate altitude is an increasingly relevant issue given the increase in displacements at moderate or high altitudes, with serious consequences such as Acute Mountain Sickness, which in its most severe degree leads to
Brain edema. Our results show that exercise can play a protective role through adaptive angiogenesis.
Christian Bason comes to MaRS for the first event of the Inspiring Action for Social Impact Series - a national program that presents international thought leaders, applied learning and practical strategies for social innovation in Canada. The Inspiring Action for Social Impact Series is presented by Social Innovation Generation (SiG), PLAN Institute and the Public Policy Forum. It will tour throughout Canada in 2011.
With the rise of the Internet, online travel agencies has been one of the most dramatic examples of the digital transformation.
This survey was made in order to better understand the online booking behaviors of Vietnamese people.
This survey was conducted among 319 respondents who use online for booking hotels, transportation or package for travelling.
The survey was conducted in June 2021.
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...GPFLR
Presentation by Ishak Yassir on how to restore and create new forest from grassland especially for supporting the reintroduction of Orangutan programs.
Findes der millioner i velfærdsteknologi?Lakeside A/S
Oplæg afholdt i forbindelse med InnovationX arrangement maj 2011. Innovation X er en fælles platform for erhvervs- og innovationsaktører i Nordjylland. Formålet er at give små og mellemstore virksomheder, erhvervsledere og iværksættere et overblik over mulighederne for rådgivning, innovation og samarbejde.
2. Vodafone mHealth Solutions 3
Vodafone mHealth Solutions Insights Guide
Welcome
!"#$%&"'(%'%)*'+*,('-".#(/'0"1.("'2)1#3$.(3%4'5'(/"'
64,37/(,'8)39":';)*'.3&'3,'(%'2*%<39"',%&"'"<39"4$"=
1.,"9',(3&)#),'(/.('>3##'"4$%)*.7"'.##'(/%,"'>%*?347'
in the different areas of healthcare to consider the
344%<.(3%4'%22%*()43(3",'(/.('.*"'4%>'.<.3#.1#"'(%'(/"&:'
!"'1"#3"<"'(/.('*".#'2*%7*",,'$.4'%4#@'1"'343(3.("9'>/"4'
.##',(.?"/%#9"*,'#%%?'1"@%49'(*.93(3%4.#'/%*3A%4,'.49'
share ideas that challenge the status quo so that together
>"'$.4'39"4(3B@'4">'>.@,'%B'.99*",,347'$)**"4('3,,)",:'
C/"'%2343%4,'"D2*",,"9'34'(/3,'
9%$)&"4('.*"'4%('%)*,'1)('(/"@'.*"'
(/%,"'%B'349"2"49"4('"D2"*(,'>/%,"'
<3">,'>"'*",2"$('5'"<"4'3B'>"'9%4E('
.#>.@,'.7*""'>3(/'(/"&:'6'(/.4?'
(/"&'B%*'(/"'(3&"'.49'"BB%*('(/"@'
/.<"'34<",("9'34'"D2#%*347'(/3,'(%23$:'
6'1"#3"<"'(/"@'/.<"'3&2%*(.4('(/347,'
(%',.@'(/.(',/%)#9'1"'%B'34("*",('(%'
.4@%4"'$%4$"*4"9'>3(/'(/"'#%47=("*&'
B)()*"'%B'(/"'/".#(/$.*"'349),(*@:
!"'/%2"'(/3,'9%$)&"4('$.4'%BB"*'@%)'
,%&"'34,37/(,'(/.('>3##'2*%<39"'(/"'
3&2"(),'(%'7"4"*.("'2%,3(3<"'$/.47":'
6('3,'(/"'+*,('%B'.',"*3",'.49'>"'#%%?'
B%*>.*9'(%'/".*347'@%)*'*",2%4,"'(%'
our ideas in the months to come.
FD"#'G"&"(A
Head of Vodafone mHealth Solutions
C/"'H%9.B%4"'-".#(/'0"1.("',"*3",'3,'2.*('%B'%)*'$%4(34)347'$%&&3(&"4('
(%'(/%)7/('#".9"*,/32'34'/".#(/$.*":'6('1*347,'(%7"(/"*',"43%*'2/.*&.I'2)1#3$'
.49'2*3<.("'/".#(/',(.?"/%#9"*,'(%'#".*4I',/.*"'.49'9"1.("'%4'3,,)",'.49'4">'
(/34?347'1*%)7/('B%*>.*9'1@'*"4%>4"9'(/%)7/('#".9"*,'.49'349),(*@'"D2"*(,:
4. Vodafone mHealth Solutions 5
Vodafone mHealth Solutions Insights Guide
Scope and !"#$%&%'$(
N''&-".#(/L'.22#3$.(3%4'%B'&%13#"'.49'
4"(>%*?'("$/4%#%73",'(%'3&2*%<"'
/".#(/$.*"'%)($%&",'%*'"B+$3"4$3",O'
P%*'(/"',$%2"'%B'(/3,'*"2%*(I'>"'
B%$),'%4'2.(3"4('.49'/".#(/$.*"'
2*%B",,3%4.#'$"4(*"9'&-".#(/',"*<3$",'
including remote care and healthcare
2*%B",,3%4.#'&%13#3,.(3%4
N''&-".#(/',"*<3$",L'34$#)9",'.4@',%B(>.*"I'
/.*9>.*"I'.49',"*<3$",'*"Q)3*"9'(%'&.?"'
(/"'"49=(%="49'&-".#(/',%#)(3%4
N''R.(3"4(,L'34$#)9",'1%(/'$%4,)&"*,'
3:":'S/".#(/@T'3493<39).#,I'.49'2"%2#"'
>3(/'.'#%47'("*&'%*'.$)("'$%493(3%4'
N''-UR,L'/".#(/$.*"'2*%B",,3%4.#,'34$#)9347'
4)*,",I'2*3&.*@'.49',"$%49.*@'$.*"'
9%$(%*,I',2"$3.#3,(,I'.49'2/.*&.$3,(,:'
C/"'7)39"'>3##'B%$),'%4'1"/.<3%)*,'>3(/34'(/"'&.()*"'
&.*?"(,'.49'&.34(.34'(/"'B%##%>347'9"+43(3%4,'(/*%)7/%)('
(/"'*"2%*(L
5. Vodafone mHealth Solutions 6
Vodafone mHealth Solutions Insights Guide
What patients and
healthcare professionals say
V",)#(,',/%>'.'7"4)34"'34("*",('34'),347'
&%13#"'("$/4%#%7@'(%'3&2*%<"'2.(3"4('$.*"'
.49'34$*".,"'"B+$3"4$3",:'-%>"<"*'<"*@'
*".#'$%4$"*4,'"D3,('.*%)49'3(,'*"#3.13#3(@I'(/"'
$%,('%B'3&2#"&"4(.(3%4'.49'(/"'.13#3(@'%B'
2.(3"4(,'(%'),"'3(:'C/"'B%##%>347'$%&&"4(,'
.*"'34$#)9"9'34'(/3,'*"2%*('(%'73<"'(/"'*".9"*'
.4'3493$.(3%4'%B'(/"'*",2%4,",'>"'*"$"3<"9'
%4',2"$3+$'(%23$,:'
W"B%*"'.4.#@,347'(/"'$/.47347'.((3()9",'(%>.*9,'
&-".#(/'343(3.(3<",I'H%9.B%4"'$%&&3,,3%4"9'*",".*$/1
34'%*9"*'(%'1"(("*')49"*,(.49'(/"'$)**"4('.22*%.$/'(%'
/".#(/$.*"'9"#3<"*@'.&%47,('/".#(/$.*"'2*%B",,3%4.#,'
.49'(/"3*'2.(3"4(,:'
Stakeholder Group What they want from mHealth
Specialists C%'/"#2'&.4.7"'9.(.'.49'&.?"'(/"'1",('),"'%B'("$/4%#%7@
GPs C%'"&2%>"*'(/"3*'2.(3"4(,'.49'/"#2'(/"&'&.4.7"'$/*%43$'
diseases
Nurses C%'.$$",,'34,(*)$(3%4.#'34B%*&.(3%4'%*'2.(3"4('9"(.3#,'%4=(/"=7%
Pharmacists C%'/"#2'(/"&'&.4.7"'2.(3"4('2*",$*32(3%4,I'"4,)*"'.$$)*.$@'
.49'/"#2'>3(/'2.(3"4('$%&2#3.4$"
Patients C%'1"(("*'&.4.7"'.49'(*.$?'(/"3*'3##4",,",
Table 1 What HCPs and Patients say
What patients have to say
R.(3"4(,'$.4',""'(/"'1"4"+('%B'&-".#(/'
1"$.),"'3&2*%<"9'.$$",,'(%'34B%*&.(3%4'
"4.1#",'(/"&'(%'1"$%&"'&%*"'.$(3<"#@'
34<%#<"9'34'(/"3*'%>4'$.*":'C/3,'3,'
2.*(3$)#.*#@'(*)"'B%*'(/%,"'>3(/'$/*%43$'
$%493(3%4,',)$/'.,'93.1"(",'%*'/37/'1#%%9'
2*",,)*":'X%13#"'("$/4%#%7@'$.4'/"#2'
them to monitor their condition outside
.'/%,23(.#'"4<3*%4&"4(:'6('&".4,'&%*"'
2"%2#"'$.4'"4Y%@'.'4%*&.#'#3B"'1)('$.4'
*".$(',>3B(#@'(%'*"$"3<"'(*".(&"4(',/%)#9'
the need arise.
6. Vodafone mHealth Solutions 7
Vodafone mHealth Solutions Insights Guide
What healthcare professionals
have to say
C/"'&.Y%*3(@'%B'/".#(/$.*"'2*%B",,3%4.#,',""'
(/"'.9<.4(.7",'%B'&-".#(/'1)('>3(/34'(/"'
,"$(%*'93BB"*"4('"&2/.,3,'3,'73<"4'(%'93BB"*"4('
"#"&"4(,:'P%*'"D.&2#"I'4)*,",'.49'8R,'.*"'
&%,('$%4$"*4"9'>3(/'3&2*%<347'2.(3"4('
$%&2#3.4$":'8R,'.#,%',""'(/.('&-".#(/'
("$/4%#%7@'$.4'*"9)$"')44"$",,.*@'2.(3"4('
<3,3(,'.49'(/"*"B%*"'$)('$%,(,:'G)*,",'%4'(/"'
%(/"*'/.49'1"#3"<"'(/.('&-".#(/'343(3.(3<",'
&.@'>"##'*"9)$"'.9&343,(*.(3%4'(3&"I'>/3$/'
>3##'34'()*4'.##%>'(/"&'(%',2"49'&%*"'(3&"'
$.*347'B%*'(/"3*'2.(3"4(,:''P34.##@',2"$3.#3,(,'
.49'2/.*&.$3,(,'1"#3"<"'(/.('&-".#(/'
,%#)(3%4,'$.4'3&2*%<"'$%&&)43$.(3%4'
>3(/'8R,',%'(/.('(/"@'$.4',/.*"'93.74%,3,'
.49'#".*4347E,'&%*"'"BB"$(3<"#@:
-"*"'3,'>/.('(/"@'/.<"'(%',.@L'
0",23("'(/3,'"4(/),3.,&'&-".#(/'.9%2(3%4'/.,'4%('1""4',$.#"9'.,'&)$/'
.,'%4"'>%)#9'/.<"'"D2"$("9:'J)1,"Q)"4('"93(3%4,'%B'(/"'H%9.B%4"'64,37/(,'
8)39"'>3##'"D2#%*"'%(/"*'*".,%4,'B%*'(/3,'34'&%*"'9"(.3#'1)('/"*"I'34'(/"'+*,('
%B'(/"',"*3",I'>"'>3##'B%$),'%4'>/.(',%&"'>%)#9'.*7)"'3,'(/"'&.34'1.**3"*'(%'
(.?"')2'5'/)&.4'1"/.<3%)*:'
Improving quality of life
ZFB("*'6'+*,('/.9'&@'+*,('/".*('.((.$?'
B%*'(/"'(/*""'>""?,'1"(>""4'(/"'+*,('
%4"'.49'(/"',"$%49'%4"'6'/.9'(%'(.?"'
&@'1#%%9'2*",,)*"'/.#B'.'9%A"4'(3&",'
.'9.@'.('(/"'9%$(%*E,'%B+$"I'.49'6'$%)#9'
/.<"'Y),('),"9'&@'2/%4"'(%'*"$%*9'3('.('
/%&"'34,(".9E'
U.*93.$'R.(3"4(I'M['
Reassurance
Z64'&@'/%,23(.#'7*%)2I'>"'7"('34'(%)$/'
%<"*'(/"'64("*4"(:'C/"*"E,',%&"%4"'(/"*"'
(%'.4,>"*'@%)*'Q)",(3%4,']'/%)*,'.'9.@I'
either a doctor or a nutritionist. I can do
3('B*%&'/%&"'%*'>%*?I'.49'3('73<",'&"'
2".$"'%B'&349:E'
03.1"(3$'R.(3"4(I'J2.34
Discretion
Z6'9%4E('>.4('%(/"*'2"%2#"'(%'B""#',%**@'
B%*'&"'1"$.),"'6E&'.'93.1"(3$I',%'6'9%4E('
>.4(I'3B'6'(.?"'%)('.'$"##'2/%4"I'"<"*@%4"'
(%'?4%>'Z%/I'(/"'2%%*'7)@'3,'.'93.1"(3$:E'
03.1"(3$'R.(3"4(I'J%)(/'FB*3$.
Caring for patients
Z6('>%)#9'1"'43$"'(%'1"',.('>3(/'(/"'
2.(3"4('.49'/.<"'.'2/%4"'(%'*"73,("*'
>/.('@%)E*"'9%347I'>/.('@%)E<"'9%4"I'
and have that recorded and logged.
6(',/%)#94E('1"'.'4)*,347'Y%1I',/%)#9'3(^
'6('(.?",'.1%)('(>%'/%)*,'.'9.@'
>*3(347'(/"'4%(",:E
G)*,"I'M[:
Improved communication
between professionals
Z&-".#(/'>3##'1"'.4'.99"9'<.#)"'1"$.),"'
(/"'7"4"*.#'2*.$(3(3%4"*'>3##'#".*4'.1%)('
93BB"*"4('2.(/%#%73",'1@'*"$"3<347'
34B%*&.(3%4'B*%&'(/"',2"$3.#3,"9'9%$(%*:E'
J2"$3.#3,(I'J2.34
C/"'B%##%>347'Q)%(.(3%4,'.*"'"D.&2#",'%B'(/"'&.34'1"4"+(,'>/3$/'>"*"'/37/#37/("9:
7. Vodafone mHealth Solutions 8
Vodafone mHealth Solutions Insights Guide
An overview of
mHealth opportunity
C/"'&-".#(/'&.*?"('3,',(3##'<"*@'@%)47'
/%>"<"*'3('3,'$#".*'(/.('(/"'%22%*()43(@'B%*'
("$/4%#%7@'9*3<"4'/".#(/$.*"'3,'(/*3<347'
as a result of a changing healthcare
"4<3*%4&"4(:'V"&%("I'34("##37"4('
&%43(%*347'.49'93.74%,3,'B%*'"D.&2#"I'/.,'
(/"'2%("4(3.#'(%'"4/.4$"'Q).#3(@'%B'#3B"I'
3&2*%<"'/".#(/$.*"'"B+$3"4$@'.49'%BB,"('
1)*7"%4347'/".#(/$.*"'$%,(,'B*%&'.'7*%>347I'
.7"347'.49'34$*".,347#@'%1","'2%2)#.(3%4:
64'.'>.@I'>"'.*"'<3$(3&,'%B'%)*'%>4',)$$",,'
.49'1@'*"9)$347'(/"'$.),",'%B'9".(/'&.4@'
&%*"'2"%2#"'.*"'4%>'#3<347'34(%'.7"'1.49,'
(/"'>%*#9'/.,4E('"D2"*3"4$"9'1"B%*"'5'>/"*"'
(/"@'4""9'&%*"'$.*"'5'.49'&%*"'"D2"4,3<"'
$.*":'-".#(/$.*"',"*<3$",'.*%)49'(/"'>%*#9'
.*"'(/"*"B%*"')49"*'2*",,)*"'(%'34$*".,"'(/"'
Q).#3(@'%B'$.*"'(%'2.(3"4(,'.('.'(3&"'>/"4'
(/"'7#%1.#'2%2)#.(3%4'3,'.7347I'(/"'1)*9"4'
of chronic disease is rising and the economic
$%493(3%4,'.*"'$/.##"47347:'64'K)*%2"I'B%*'
"D.&2#"I'(/"'%<"*=_`,I'>/%,"'/".#(/$.*"'
$%,('1)*9"4'3,'B%)*'(3&",'(/.('%B'@%)47"*'
.7",I'>3##'.$$%)4('B%*'.('#".,('`a'%B'
(/"'2%2)#.(3%4'1@'b]b
:'F#%47,39"'(/3,I'
)4/".#(/@'#3B",(@#"'$/%3$",',)$/'.,'
,&%?347'.49'2%%*'93"(I'(/"'34$*".,347'*3,?'
%B'.49'$%4$"*4'.*%)49'(/"'2%("4(3.#'3&2.$('
%B'2.49"&3$'93,".,",I'(/"'#3&3("9'4)&1"*'
.49')4"<"4'93,(*31)(3%4'%B'/".#(/$.*"'
>%*?"*,I'2%%*'9*)7'93,(*31)(3%4'.49'(/"'
#"47(/@'9"<"#%2&"4('$@$#",'%B'4">'
&"93$34",'.*"'$%&134347'(%'&.?"'(/"'
$%,('%B'/".#(/$.*"'.#&%,(')4,),(.34.1#"'
2.*(3$)#.*#@'34'&.()*"'&.*?"(,:'
64'.993(3%4I'&.4@'/".#(/$.*"'2*%<39"*,'34'
9"<"#%2"9'&.*?"(,'.*"'"4$)&1"*"9'1@'
#"7.$@'34B*.,(*)$()*",'(/.('/.<"'1""4')4.1#"'
(%'.9.2('(%'&""('(/"'$/.47347'4""9,'%B'
(/"'<"*@'2"%2#"'(/"@'>"*"'9",374"9'(%'
2*%("$(:'J&.##'>%49"*'(/.('&.4.7"&"4('
$%4,)#(.4(,'X$[34,"@'2*"93$('(/.('3B'#"B('.,'3('
3,I'/".#(/$.*"'$%,(,'$%)#9'*".$/'cb'2"*'$"4('
%B'80R'1@'b]b:'C/"';KU0'3,'4%('B.*'1"/349'
>3(/'$%,(,'*".$/347'cb'2"*'$"4('%B'(/"'
&"93.4'80R'1@'bdb:'64'"&"*7347'&.*?"(,'
,)$/'.,'FB*3$.'>/"*"'.9)#('&%*(.#3(@'*.(",'.*"'
%<"*']bb'2"*'eIbbb'2%2)#.(3%4,I'.#%47,39"'
$%,(I'#.$?'%B'34B*.,(*)$()*"I'#3&3("9'.$$",,'(%'
(*".(&"4(,'.49'2%%*'Q).#3(@'&"93$34",'
.*"'(/"'$%*"'/".#(/$.*"'2*%1#"&,:'
f%%?347'./".9'3('3,'/%2"9'(/.(',&.*("*'
("$/4%#%73",'>3##'/"#2'(%'3&2*%<"'
$%&&)43$.(3%4,'1"(>""4'2.(3"4(,I'
/".#(/$.*"'2*%<39"*,'.49'(/%,"'(/.('2.@'.49'
&.4.7"'(/"',@,("&:'F,'.'*",)#('(/3,'/.,'(/"'
2%("4(3.#'(%'3&2*%<"'2.(3"4('B*""9%&'.49'
349"2"49"4$"I'*"9)$"'(/"'%<"*.##'$%,('.49'
3&2*%<"'2.(3"4('$.*":'C/3,'<3">'3,',)22%*("9'
1@'X$[34,"@'(/.('",(3&.(",'(/.('(/"'("#"=
/".#(/'%*'&-".#(/'349),(*@'>3##'1"'>%*(/'
%<"*'MJ'g`b'13##3%4'1@'(/"'"49'%B'(/"'9"$.9":
F'&.Y%*'7#%1.#'$/.##"47"'3,'/%>'(%'#%%?'
.B("*'%)*'"#9"*#@'.49'(/"'$/*%43$.##@'3##:'
X.4@'1"#3"<"'(/.('*%1%(3$'.,,3,("9'$.*"'
.49'*"&%("'&%43(%*347'>3##'%BB"*'<3.1#"'
,)22%*(:'C%9.@'7*%>347'4)&1"*,'%B'2)1#3$'
.49'2*3<.("'%*7.43,.(3%4,'/.<"'&%<"9'%4'
B*%&'1.,3$',@,("&,'%B'4)*,"'<3,3(,'.49'.*"'
.#*".9@'2*%<39347'("#"=/".#(/'1.,"9',)22%*('
(%'&%43(%*'<3(.#',374,'(/*%)7/'9.(.'#34?,I'
73<"'.9<3$"'%<"*'(/"'2/%4"'.49'.##%>'
*"&%("'3&.7347:'C"D('1.,"9',)22%*('%B'
&)#(32#"'2.(3"4(,'/.,'.#,%'2*%<"9'/37/#@'
"BB"$(3<"'B*%&'1%(/'(/"*.2")(3$'.49'
"$%4%&3$'2"*,2"$(3<",'34'&.4@'$%)4(*3",'
B*%&'(/"'R/3#32234",'(%'J%)(/'FB*3$.I'
8"*&.4@'(%'W*.A3#:
By Dr Tim JonesI'P%)49"*'.49'R*%7*.&&"'03*"$(%*'%B'
P)()*"'F7"49.I'.'7#%1.#'%2"4'B%*",37/('343(3.(3<"'
8. Vodafone mHealth Solutions 9
Vodafone mHealth Solutions Insights Guide
64'(/"'4"D('9"$.9"'("#"&"93$34"'
$%44"$(3<3(@'>3##'2*%<39"']hd'&"93$.#'
9.(.',/.*347'1"(>""4'2.(3"4(,'.49'
/".#(/$.*"'2*%B",,3%4,'>3(/'<39"%'#34?,I'
>".*.1#"'&%43(%*347'"Q)32&"4('.49'34=
/%&"',"4,%*,'(*.$?347'&%<"&"4(I'1%9@'
("&2"*.()*"'.49'%(/"*'<3(.#',374,:'C/"'
$%4,"Q)"4$"'%B'(/3,'>3##'1"'(/.('2.(3"4(,'
>3##'1"'.1#"'(%'*"(.34'(/"3*'349"2"49"4$"'
B%*'#%47"*'.49',%'1"(("*'"4Y%@'#3B"'%)(,39"'
(/"'&.34,(*".&'$.*"',@,("&:'J%&"'
commentators as a result envisage a
,#%>=9%>4'34'(/"'*"$"4('7*%>(/'%B'4)*,347'
/%&",'.,'.'7*".("*'2*%2%*(3%4'%B'(/"'"#9"*#@'
remain at home. While some suggest that
(/3,'34'()*4'$%)#9'&".4'34$*".,"9'2/@,3$.#'
3,%#.(3%4I'(/"'.&13(3%4'B%*'%(/"*,'3,'(%'),"'
("$/4%#%7@I'2.*(3$)#.*#@'&%13#"'("$/4%#%7@I'
(%'2*"<"4('2"%2#"'B*%&'B""#347'#%4"#@:'64'.'
>%*#9'>/"*"'%4'.<"*.7"'B.&3#@',)22%*('B%*'
(/"'%#9"*'7"4"*.(3%4'>3##'$%4(34)"'(%'9"$#34"'
.49'(/"'$%,('%B'2*%<39347'2"*,%4.#'$.*"*,'
>3##'$%4(34)"'(%'*3,"I'"#9"*#@'2.(3"4(,'.49'
(/%,"'>3(/'#%47'("*&'$/*%43$'93,".,",'.*"'
34$*".,347#@'#3?"#@'(%',""',%&"',("2'$/.47",'
34',)22%*('%<"*'(/"'4"D('B">'@".*,:'
In addition to automated care there is
7"4"*.#'$%4,"4,),'(/.('1"(("*'),"'%B'
2.(3"4('9.(.'3,'<3(.#'(%'3&2*%<"'"B+$3"4$3",'
5'2.*(3$)#.*#@'B%*'(/%,"'>3(/'%4=7%347I'
$/*%43$'$%493(3%4,',)$/'.,'93.1"(",:'C"$/=
,.<<@'93.1"(3$',)BB"*"*,'.#*".9@'1"4"+('
B*%&'.'7*%>347'4)&1"*'%B'&%13#"'2/%4"'
.22#3$.(3%4,'(/.('$.4'/"#2'*"$%*9'.49'(*.$?'
3493<39).#'&".,)*",I'93"('.49'2"*B%*&.4$"'
.49'(/"*"'.*"'34$*".,347'4)&1"*,'%B',@,("&,'
(/.('.##%>'(/"',/.*347'%B'9.(.'1"(>""4'
2.(3"4(,'.49'(/"3*'9%$(%*,:'W)3#9347'%4'(/3,I'
,"<"*.#'%*7.43,.(3%4,',)22%*('(/"'4%(3%4'
(/.('2""*=(%=2""*'.49'"D2"*('2.(3"4('7*%)2,'
&.@'/.<"'.,'&)$/'34i)"4$"'%4'3493<39).#'
1"/.<3%)*'.,'(/"'&%*"'(*.93(3%4.#'2.(3"4(=
/".#(/$.*"'2*%B",,3%4.#'*"#.(3%4,/32I',%'
"D2"$('(%',""'&%*"'2.(3"4('9.(.'1"$%&347'
&%*"'<3,31#"'.49'&%*"',/.*".1#"'.$*%,,'
2#.(B%*&,'.49',@,("&,'34'@".*,'(%'$%&":
6B'>"'$.4')(3#3,"'(/"'%22%*()43(@'(/.('(/"'
)13Q)3(@'%B'&%13#"'$%&&)43$.(3%4'%BB"*,I'
>"'$.4'1"(("*'B.$3#3(.("'(/"'9"#3<"*@'%B'&%*"'
"B+$3"4('.49'"BB"$(3<"'/".#(/$.*":'dba'%B'(/"'
,3D'13##3%43
'&%13#"',)1,$*31"*,'34'(/"'>%*#9'
(%9.@'#3<"'34'9"<"#%2347'$%)4(*3",'>/"*"'
(/"'4""9'B%*'(/"'2*%<3,3%4'%B'$.*"',"*<3$",'.('
2%34('%B'4""9'3,'7*".(",(:'
KD2"*3"4$"'/.,',/%>4'),'(/.('(/"*"'3,'.'
7*".('>3##3474",,'(%'),"'&%13#"'("$/4%#%7@'
>/"*"'(/"'7"4"*.#'2*%<3,3%4'%B'1.,"#34"'
/".#(/$.*"'3,'>".?",(:'C/"*"B%*"'3('3,'2"*/.2,'
)4,)*2*3,347'(%',""'(/.('(/","'2.*(,'%B'
(/"'>%*#9I')4"4$)&1"*"9'.,'(/"@'.*"'1@'
#"7.$@'34B*.,(*)$()*",I'/.<"'9"&%4,(*.("9'
.4'.13#3(@'(%'1"'43&1#"'34'(/"3*'.9%2(3%4'
%B'4">',%#)(3%4,'(/.('$.4'9"#3<"*'9"$"4('
2"*B%*&.4$"'.('.'#%>'$%,(:'649""9'(/"'
"&"*7347'>%*#9'/.,'1"$%&"'.'$.,"',()9@'
for healthcare innovation.
F'7%%9'"D.&2#"'%B'/%>'&.()*"'&.*?"(,'
.*"'#".*4347'B*%&'%(/"*,'$.4'1"'B%)49'
34'6493.'>/"*"'G.*.@.4.'-%,23(.#'/.,'
),"9'.'$%&134.(3%4'%B'1),34",,'&%9"#'
.49'2*%$",,'344%<.(3%4'(%'#%>"*'(/"'$%,('
%B'$.*93.$',)*7"*@'.49'34'9%347',%'/.,'
*"<%#)(3%43,"9'(/"'.$$",,I'<%#)&"'.49'*".$/'
%B'3(,'B.$3#3(3",'(%'1"$%&"'%4"'%B'(/"'B.,(",('
7*%>347'/".#(/$.*"'1),34",,",'34'(/"'>%*#9:'
F$$%*9347'(%'(/"'!JjI'j.$?'f">34I'UK;'%B'(/"'
F&"*3$.4'U%##"7"'%B'U.*93%#%7@I'(/"'#.*7"'
4)&1"*'%B'2.(3"4(,'2.,,347'(/*%)7/'(/"'
G.*.@.4.'B.$3#3(3",'.##%>,'3493<39).#'9%$(%*,'
(%'B%$),'%4'%4"'%*'(>%',2"$3+$'(@2",'%B'
$.*93.$',)*7"*3",'.49',%'9"<"#%2'2.*(3$)#.*'
,?3##,:'SG.*.@.4.'/.,'4%('%4#@'1"$%&"'(/"'
1",('2#.$"'(%'/.<"'/".*(',)*7"*@'1)('3('/.,'
.#,%'1"$%&"'(/"'7%=(%'B.$3#3(@'B%*'.##'.,23*347'
$.*93.$',)*7"%4,'7#%1.##@T:'
j.$?'f%*9I'UK;'%B'G.<37"43$,I'.)(/%*'%B'(/"'
343(3.#'2"*,2"$(3<"'%4'-".#(/'B%*'(/"'P)()*"'
F7"49.'R*%7*.&&"'%1,"*<"9'(/.(I'S%4'(/"'
2*%<3,3%4347'%B'/".#(/$.*"I'34"*(3.',""&,'
(%'1"'(/"'7*".(",('B%*$"T'.49'>"4('%4'(%'
2*"93$('(/.('S(/"'4"D('9"$.9"'3,'4%('(%'1"'
.'(3&"'%B'$/.47"'1)('34,(".9'.'(3&"'(/.('
,(*",,%*,'%4'(/"',@,("&'1"$%&"'
2*%7*",,3<"#@'"<39"4(O'34$*".,"9'1)*9"4,'
%B'9"&%7*.2/@'.49'$/*%43$'3##4",,'>3##'
*"&.34')4.1.("9T:'6WX'34'(/"3*'J&.*("*'
R#.4"('.4.#@,3,'1)3#9,'%4'(/3,'1@',.@347I'
SC/"'2*%1#"&,'>3(/'%)*'/".#(/$.*"',@,("&'
.*"'>"##'?4%>4'.49'>"##'9%$)&"4("9'5'.49'
"49#",,#@'9"1.("9:'!/.(E,'4%(',%'.22.*"4('
3,'(/.('&.4@'%B'(/"&'.*3,"'1"$.),"'%)*'
/".#(/$.*"',@,("&'3,4E(I'34'B.$(I'.',@,("&:T'
The need to address the rationale for this
34"*(3.'3,'2*",,347'.49'3(',""&,'$#".*'(/.('
&%13#"'("$/4%#%7@'/.,'.'?"@'*%#"'(%'2#.@'
in facilitating change.
Z!"'.*"'34'.'2"*B"$(',(%*&:'k%)E<"'7%('/".#(/$.*"'*"B%*&O'@%)E<"'7%('.4'"$%4%&3$'
9%>4()*4:::'>"'/.<"'.',/%*(.7"'%B'2*%<39"*,:'!"'/.<"'.'2*",,)*"'(%'.9%2('"#"$(*%43$'
*"$%*9,:'!"E<"'7%('.4'.7347'2%2)#.(3%4:'F49'@"(I'.('(/"',.&"'(3&"'>"'/.<"'(/","'
"&"*7347'4">'34B%*&.(3%4I'$%&&)43$.(3%4'("$/4%#%73",'(/.('$.4'/"#2'),'4.<37.("'
(/.('2"*B"$(',(%*&:E'
0.#"'F#<"*,%4I'R*",39"4('%B'(/"'F&"*3$.4'C"#"&"93$34"'F,,%$3.(3%4
!/"(/"*'34'(/"'9"<"#%2347'
"$%4%&3",'%*'34'(/"'!",('&%13#"'
("$/4%#%7@'/.,'.',3743+$.4('
*%#"'(%'2#.@:'6('$.4'9*.&.(3$.##@'
3&2*%<"'(/"'"B+$3"4$@'%B'
/".#(/$.*"'9"#3<"*@'&%9"#,I'B*%&'
,3&2#"'("D('&",,.7"'*"&349"*,I'
(%'3&2*%<347'$%&2#"D',)22#@'
$/.34'2*%$",,",'34'*"&%("'.*".,:'
6('3,'.#,%'>"##',)3("9'(%'3&2*%<347'
2.(3"4('$.*"I'%BB"*347'&"93$.#'
2*%B",,3%4.#,'(/"'.13#3(@'(%'$%##"$('
*".#=(3&"'93.74%,3,'B%*'$#343$.#'
(*3.#,I'73<347'$/*%43$'93,".,"'
sufferers the chance to live more
$%&B%*(.1#@'.49'349"2"49"4(#@'
.('/%&"'.49'2*%<39347'/".#(/$.*"'
>%*?"*,'.$$",,'(%'34B%*&.(3%4',%'
(/.('(/"@'$.4'(*".('&%*"'2.(3"4(,'
&%*"'"BB"$(3<"#@:'
9. ''H%9.B%4"'&-".#(/'J%#)(3%4,''eb
Vodafone mHealth Solutions Insights Guide
Evaluating behaviour
to marketed mHealth
services
F,'&-".#(/'343(3.(3<",'"<%#<"'B*%&'23#%('(%'
&.34,(*".&I'(/3,',"$(3%4'39"4(3+",',%&"'
$%&&%4'.((*31)(",'%B'(/"'&%*"',)$$",,B)#'
343(3.(3<",'%2"*.(347'(%9.@'.$*%,,'.'4)&1"*'
%B'$%)4(*3",'34'(/"'9"<"#%2"9'>%*#9:'
A rapidly evolving space, favouring
the newcomer
&-".#(/'$%&134",'(/"'&%13#"I'6C'.49'
/".#(/$.*"'349),(*3",I'>/3$/'.##'/.<"'
93BB"*"4('2#.@"*,I'2.@"*,I'$)#()*",I'$#%$?'
,2""9,'.49'.((3()9",'(%>.*9,',"$)*3(@I'
2*3<.$@'.49'Q).#3(@:'C/3,'9@4.&3$'.*".'
B.<%)*,'4">$%&"*,I'.49'349""9'&%,('%B'
(/"'$%&2.43",'*"B"*"4$"9'34'(/3,',"$(3%4'
.*"'<"4()*"=1.$?"9',(.*(=)2,'>3(/'*.239#@'
7*%>347'),"*'1.,",'.49',(*%47'$.,/'2%,3(3%4,:'
A space that covers both healthcare
and wellness
C/"'$#".*",('93,(34$(3%4'1"(>""4'
93BB"*"4('$%&2.43",'3,'1"(>""4'/".#(/'
$.*"'.49'>"##4",,O'(/"'B%*&"*'("49'(%'1"'
*"7)#.(%*@=.22*%<"9'&"93$.#'9"<3$",'.49'
,"*<3$",'),"9'1@'9%$(%*,I'>/3#"'(/"'#.(("*I'
,)$/'.,'$.#%*3"'$%)4("*,I'+(4",,'1)993",'
.49',#""2'&%43(%*,I'.*"'(.*7"("9'
at consumers. Wellness solutions
7"4"*.##@'),"'1"/.<3%)*'$/.47"'(%'
9"#3<"*'>"##4",,'7%.#,'l,)$/'.,'#%>"*347'
$.#%*3",I'%*'3&2*%<347'.'`?'*)4'(3&"m'
>/3#"'/".#(/$.*"',%#)(3%4,'.*"'%B("4'9.(.'
7.(/"*"*,'.,'2.*('%B'.'#.*7"*'$#343$.#'
2*%$",,'l,)$/'.,'/".*('&%43(%*,'.49'&%13#"'
XV6,'lX.74"(3$'V",%4.4$"'6&.7347mm:'
Tools for chronic disease management
,)$/'.,'93.1"(",I'/@2"*("4,3%4'.49'
.,(/&.'("49'(%'9*.>'B*%&'1%(/'$.&2,I'
.49'*"2*","4(',%&"'%B'(/"'&%,('"D$3(347'
%22%*()43(3",'B%*'#%>"*347'$%,(,'.49'
3&2*%<347'2.(3"4('%)($%&",:'
C/"'.((*31)(",'#3,("9'/"*"'.*"'$.("7%*3,"9'
.$$%*9347'(%'.9%2(3%4I'"47.7"&"4('.49'
3&2.$('l.#,%',""'+7)*"em:'C/","'>%4E('
.22#@'"Q).##@'(%'.##'$%&2.43",I'/%>"<"*'
&.4@',)$$",,B)#'$%&2.43",'"D/313('(/"'
&.Y%*3(@'%B'(/","'.((*31)(",:'
By Stephen Johnston, Founder and CEO of Fordcastle LLC
>/3$/'/"#2,'9"<"#%2'$%&2.43",'(%'1)3#9'%22%*()43(@'
.*%)49'&%13#"'("$/4%#%7@I'/".#(/$.*"'.49'#%47"<3(@'
Figure 1 The common attributes of
successful mHealth services
IMPACTENGAGEMENT
ADOPTION
Simplicity
Empatheticdesign
Comprehensiveness
Interactive
Customerdelight
Uservalue
Joined-upsolutions
Clincalandeconomicresults
10. Vodafone mHealth Solutions 11
Vodafone mHealth Solutions Insights Guide
F9%2(3%4'
1. Simplicity
8%%7#"E,'F49*%39'.49'F22#"E,'3;J'/.<"'
&.9"'7*".(',(*39",'.('&.?347'$%&2#"DI'
&)#(3=B".()*"9',&.*(2/%4",',3&2#"I'.49'
/.<"'1""4'*">.*9"9'>3(/'.'$%&134"9'_na'
&.*?"(',/.*"'7#%1.##@'34'oc'bee4
:'-%>"<"*I'
(/"'&.Y%*3(@'%B'9"<3$",'34'2"%2#"E,'/.49,'
34'9"<"#%2"9'$%)4(*3",'.*"',(3##'Z9)&1EI'.49'
/".#(/$.*"'2.(3"4(,'34'2.*(3$)#.*'.*"'#3?"#@'
(%'1"'#",,'("$/',.<<@'(/.4'.<"*.7":'649""9I'
%4"'*"$"4(',()9@'B%)49'(/.('%4#@'`a'%B'
2.(3"4(,'>3(/'$/*%43$'93,".,",'>"*"'64("*4"('
users at all5
'l#"('.#%4"'&%13#"'64("*4"('),"*,mI'
>"##'1"#%>'(/"'.<"*.7"'.9)#('2"4"(*.(3%4'
%B'dna6
.
C"D('&",,.7347',"*<3$",'.*"'"BB"$(3<"'.('
9"#3<"*347'1.,3$',"*<3$",I',34$"'(/"@'>%*?'%4'
.#&%,('"<"*@'2/%4"'.49'(/"'*"$323"4('*".9,'
p`a'%B'("D('&",,.7",'>3(/34'B%)*'&34)(",'
of receiving.
H%D3<.I'B%)49"9'34'bbeI'2*%<39",'
C"D(]W.1@'(/.('9"#3<"*,'(/*""'("D(,'.'>""?'
(%'2*%,2"$(3<"'&%(/"*,'.B("*'(/"@'*"73,("*'
(/"3*'13*(/'9.("'),347'.',/%*('$%9":'C/"'("D('
&",,.7",'$%4(.34'"9)$.(3%4.#'$%4("4(I'
*"&349"*,'.49',)*<"@,:'G%>'>3(/'c`?'
,)1,$*31"*,I'(/"',"*<3$"'3,'7*%>347'.('e`?'
),"*,'2"*'&%4(/I'.49',3743+$.4(#@I'%4#@'
cca'%B'.##'),"*,'"<"*'*"73,("*"9'/.<"'
cancelled the service.
C/3,'Z,"('3('.49'B%*7"('3(E'$%4$"2('>%*?,'>"##O'
2.,,3<"',"*<3$",'("49'(%'*"(.34'),"*,'1"(("*'
(/.4'(/%,"'$%4,(.4(#@'*"Q)3*347'9.(.'"4(*@:'
X.4@'$.#%*3"'$%)4("*'.22,'/.<"'i%)49"*"9'
B%*'(/3,'*".,%4I'>/"*".,'>"##4",,'9"<3$",'
,)$/'.,'(/"'!3(/347,'!3=P3'"4.1#"9'1.(/*%%&'
,$.#"I'(/"'P3(13('>".*.1#"'1%9@'&%43(%*'.49'
(/"'q"%',#""2'(*.$?"*'.##'.)(%&.("'9.(.'
$.2()*"'.49'"4(*@'.B("*'343(3.#',"(')2:'
2. Empathetic design
X.*"?'R.>#%>,?3I'B%)49"*'%B'(/"'X%13#"'
M,"*'KD2"*3"4$"'U%4B"*"4$"I'),"9'(/"'("*&'
Z"&2.(/"(3$'9",374E'(%'9",$*31"'(/"'2*%$",,'
%B'"4,)*347'9",374"*,'*".##@'9%'(.?"'(/"'
needs of the end user into consideration.
F('%4"'%B'(/"3*'>%*?,/%2',",,3%4,'%4'
/".#(/$.*"I'2.*(3$32.4(,'34'.'1*.34,(%*&347'
%4'&%13#"'/".#(/'9"<3$",'B%*'(/"'"#9"*#@'
>"*"'73<"4'7#%<",'.49',/.9"9'7#.,,",'(%'
3##),(*.("'(/"'$/.##"47",'B.$"9'>/"4'2"%2#"'
>3(/'<3,).#'.49'2/@,3$.#'3&2.3*&"4(,'/.9'(%'
34("*.$('>3(/'&%13#",:'
C/"'j3(("*1)7'2/%4"'.49',"*<3$"'&.9"'1@'
8*".('U.##'3,'.'&%13#"',%#)(3%4'9",374"9'
>3(/'(/"'4""9,'%B'.7347'),"*,'34'&349'5'>3(/'
#.*7"'?"@,'.49',3&2#"',"*<3$"'%2(3%4,:'C/"@'
offer a medication reminder service for an
.993(3%4.#'&%4(/#@'$/.*7"'(/.('9"#3<"*,'
*"7)#.*'<%3$"'*"&349"*,'(%',)1,$*31"*,'(%'
(.?"'(/"3*'&"93$.(3%4:'
3. Comprehensiveness
P%*',%&"'&-".#(/',%#)(3%4,I'(/"'?"@'(%'
,)$$",,'#3",'34'(/"3*'$%&2*"/"4,3<"4",,:'
P%)49"9'34'eppnI'K2%$*.(",'3,'%4"'%B'(/"'
B">'2)1#3$'$%&2.43",'#3,("9'/"*"'.49'/.<"'
%<"*'.'9"$.9"E,'"D2"*3"4$"'$%##"$(347'.49'
%*7.43,347'$%4("4('B%*'2/@,3$3.4,:'C/"3*'9*)7'
*"B"*"4$"I'"9)$.(3%4.#'.49'$#343$.#',%#)(3%4,'
.*"'34'),"'1@'e:c&'/".#(/$.*"'2*%B",,3%4.#,I'
34$#)9347'%<"*'/.#B'%B'(/"'9%$(%*,'34'(/"'MJI'
>/%'*"#@'%4'3(,'$%&2*"/"4,3<"4",,:
;4'(/"'$%4,)&"*',39"I'(/"'3C*3.7"'.22'(/.('
/.,'1""4'9%>4#%.9"9'.#&%,('(/*""'&3##3%4'
(3&",I',"",')2'(%'%4"'&3##3%4'&%4(/#@'),"*,'
.49'1%.,(,'ebIbbb'l&%,(#@'2%,3(3<"m'*"<3">,'
%4'F22#"E,'F22,(%*":'UK;'R"("*'-)9,%4I'
X0I'/37/#37/(,'3(,'349),(*@=#".9347'$%4("4('
.77*"7.(3%4'$.2.13#3(3",'l34'.993(3%4'(%'
,(*%47'$),(%&"*',)22%*(m'.,'.'?"@',)$$",,'
B.$(%*:'C/"@'2*%<39"'34B%*&.(3%4'.1%)('
,@&2(%&,'.,'>"##'.,'34("7*.(3%4'34(%'
/)49*"9,'%B'2.*(4"*'/".#(/$.*"'2*%<39"*,I'
*",)#(347'34'>/.('3,'"BB"$(3<"#@'1"$%&347'.'
White Pages of consumer health services.
Engagement
4. Interactive
R*%<39347'2"*,%4.#3,"9'B""91.$?'(/.('.##%>,'
users to see the results of their actions
&.?",'B%*'.'&%*"'"47.7347'"D2"*3"4$":'
The Consumer Health Information
U%*2%*.(3%4'lU-6Um'B%)49'(/.('.'Q).*("*'%B'
.##',&.*(2/%4"'.22,'l4%('Y),('/".#(/'.22,m'
>"*"'9*%22"9'.B("*'(/"'+*,('7%I'.49'(/*""=
Q).*("*,'>"*"'4%'#%47"*'),"9'.B("*'(/"'("4(/'
(*@:'V".,%4,'B%*'9*%22347'.4'.22'34$#)9"9'
+49347'.'1"(("*'%4"'lc]:]amI'3(,'#.$?'%B'
S),"*'B*3"49#34",,T'lc:_amI'%*'3('4%('1"347'
"47.7347'"4%)7/'le`:nam:';B'.',)*<"@'%B'
cp`'$%4,)&"*,I'.1%)('nba',.39'(/"@'
>%)#9'1"'&%*"'&%(3<.("9'(%'),"'.4'.22'
(/.('>%)#9'.4.#@,"'9.(.'(/"@'*"$%*9"9'
.49'2*%<39"'B""91.$?7
.
-".#(/$.*"'("$/4%#%7@'$%&2.4@'
!"##0%$I'64$:')49"*,(.49,'(/3,:'
C/"3*'i.7,/32'03.1"(",X.4.7"*®
I'(/"'+*,('
&%13#"'93.1"(",'&.4.7"&"4(',%#)(3%4'(%'
*"$"3<"'P0F'`eb['$#".*.4$"I'2*%<39",'
,3&2#"'.49'2*%<"4I'$#343$.#'.49'1"/.<3%)*.#'
"<39"4$"=1.,"9'7)39.4$"'.1%)('/%>'(%'
&.4.7"'7#)$%,"'#"<"#,I'&"93$.(3%4,I'
.$(3<3(@I'93"('.49',"<"*.#'%(/"*'2.*.&"("*,'
>/3$/'.BB"$('(%(.#'93.1"(",'>"##4",,:'
U%&2.4@'R*",39"4('F4.49'6@"*',"",'3('.,'
.'S&%13#"'<3*().#'$%.$/347',%#)(3%4T'(/.('
2*%<39",'1.,3$'$#343$.#'.49'1"/.<3%)*.#'
,)22%*(I'"BB"$(3<"#@'2*%<39347'.4'34("*.$(3<"'
$%.$/'34'2"%2#"E,'2%$?"(,:
11. ''H%9.B%4"'&-".#(/'J%#)(3%4,''e
Vodafone mHealth Solutions Insights Guide
Z!"E<"',""4'&.4@'2*%7*.&&",'(/.('/.<"'1""4'7*.4('B)49"9:'C/"'7*.4('"49,'.49'(/"'
2*%7*.&&"'"49,:'J%'>"'.,?'2"%2#"'(%'(/34?'.1%)(',),(.34.13#3(@'.49'(%'$%&"')2'>3(/'
.'1),34",,'2#.4'(/.('&.?",',"4,":'!/.(E,'(/"'9.(.'>"'4""9'(%'$%##"$('(%',/%>'(/"'
3&2.$('.49'>/.('.*"'(/"'3493$.(%*,'%B',)$$",,:'k%)E<"'7%('(%'1"'.1#"'(%'9"("*&34"'(/.(:'
C"#"/".#(/'>3##'4%('1"',),(.34"9'%*'.9%2("9')4#",,'>"'$.4',/%>'(/.('3('3&2*%<",'/".#(/'
%)($%&",'.49'*"9)$",'$%,(,:E'
U#343$3.4I'MJ
5. Customer delight, even fun
P)4$(3%4'/.,'7"4"*.##@'(*3)&2/"9'%<"*'
B%*&'34'(/"'/".#(/$.*"'1),34",,I'>/3#"'34'
(/"'$%4,)&"*'"#"$(*%43$,'.49'&%13#"',2.$"'
.'<.,('.&%)4('%B'(3&"'3,',2"4('(/34?347'
.1%)('),"*'"D2"*3"4$":'
C/"'W%,(%4I'XF=1.,"9',(.*(=)2'
P3(4",,[""2"*'/.,'.((*.$("9'_&'),"*,'(%'3(,'
V)4[""2"*',"*<3$"'>3(/%)(',2"49347'.'$"4('
%4'.9<"*(3,347:'P%)49"*'r'UK;'j.,%4'j.$%1,'
(/34?,'(/.('S1)3#9347'.'2*%9)$('2"%2#"'
#%<"T'3,'(/"'?"@'(%'(/3,'%*7.43$'7*%>(/:'64'
.993(3%4I'/"'$3(",'(/"',%$3.#'$%&2%4"4(I'
.$$"#"*.("9'1@'P.$"1%%?'.49'C>3(("*I'.49'
(/"'$%&&)43(@',)22%*(I'.,',)$$",,'B.$(%*,:'
0"#37/('9%",4E('/.<"'(%'1"'*","*<"9'B%*'
>"##4",,'.22,:'C/"'B%)49"*,'%B'HU=1.$?"9'
,(.*(=)2'X.,,3<"'-".#(/'.*"'),"*'"D2"*3"4$"'
"D2"*(,'>3(/%)('/".#(/$.*"'1.$?7*%)49,I'
.49'/.<"'<%>"9'(%'1*347'$),(%&"*'9"#37/('
(%'(/"'+"#9'%B'/".#(/$.*":'C/"@'.*"'$)**"4(#@'
1"(.'(",(347'(/"3*'+*,('2*%9)$(I'.'93.1"(",'
&.4.7"&"4(',%#)(3%4I'.49'UK;'J)(/.'
[.&.#',.@,'(/.(')#(3&.("#@'/"E,'S#%%?347'
B%*'(/"'7*34T'%4'(/"'),"*E,'B.$":'64'.993(3%4I'
344%<.(3<"'2*%Y"$(,'.*"'),347'X3$*%,%B(E,'
[34"$(E,'&%(3%4=,"4,347',%#)(3%4'(%'.,,",,'
".*#@'93,".,"',@&2(%&,8
I'.49'7.&"'
9@4.&3$,'.*"'1"347'),"9'(%'"4$%)*.7"'
&"4(.#'.49'2/@,3$.#'+(4",,I',)$/'.,'>3(/'
-)&.4.E,'U%#%*B.##:
6&2.$(
6. User value
J&.*(',%#)(3%4,'9%'&%*"'(/.4'Y),('
*"2#3$.("'"D3,(347'2*%$",,",'%4',&.##'
,$*""4,I'(/"@'#%%?'B%*'>.@,'34'>/3$/'(/"'
2*%$",,'$.4'1"'9%4"'1"(("*I'9"#3<"*347'
#.,(347'),"*'1"4"+(,'(/.(',3743+$.4(#@'
%)(>"37/'.4@'$%,(,'34$)**"9:'
FA)&3%E,'Z64,(.4('-".*('V.("E'.22'9"#3<"*,'
Y),('>/.('3('2*%&3,",I'(.?347'(/"'/".*('*.("'
B*%&'(/"'+47"*'34'Y),('.'B">',"$%49,:'6('
),",'(/"'2/%4"E,'34=1)3#('$.&"*.'$%&134"9'
>3(/'(/"'#37/('B*%&'(/"'i.,/'(%'(*.$?'$%#%)*'
$/.47",'34'(/"',?34'(/.(',/%>'/".*('*.(":'
C/3,'344%<.(3<"'.22*%.$/I'(%7"(/"*'>3(/'.4'
attractive user interface has resulted in this
.22'1"347'9%>4#%.9"9'eb'&3##3%4'(3&",'1@'
;$(%1"*'bebO'.('gb:pp'.'9%>4#%.9I'(/3,'/.,'
1"$%&"'%4"'%B'&-".#(/E,',)$$",,',(%*3",:'
J%#)(3%4,'(/.('&.?"'B)##'),"'%B'(/"'&)#(3=
B.$"("9'2%>"*'%B'(/"'&%13#"'$.4'9"#3<"*'
even more value to users than those that
Y),('*"2#3$.("'"D3,(347'%Bi34"'2*%$",,",:'
C/3,'3,'",2"$3.##@'3&2%*(.4('>/"4'%4"'
$%4,39"*,'(/"'&@*3.9'%B'"D3,(347'93,(*.$(3%4,'
%4'(/"'2/%4"'(/.('.*"'.#*".9@'$%&2"(347'
B%*'(/"'),"*E,'.(("4(3%4I',)$/'.,'?""2347')2'
>3(/',%$3.#'4"(>%*?,I'$%4,)&347'&"93.'%*'
2#.@347'7.&",:
7. Clinical and economic results
-".#(/=B%$),"9',%#)(3%4,'(/.('$.4',/%>'
1%(/'$#343$.#'.49'"$%4%&3$'1"4"+(,'(%'.##'
2.*(3",'>3##',""'(/"'&%,('*.239')2(.?":'
F3*J(*32'C"$/4%#%73",'9"#3<"*,'4".*'*".#=(3&"'
>.<"B%*&'.49'%(/"*'*"#"<.4('$#343$.#'9.(.'(%'
.'2/@,3$3.4E,',&.*(2/%4":'C/"'$%&2.4@E,'
;W'2*%9)$('/.,'1""4',%',)$$",,B)#'
34'*"9)$347'/)&.4'"**%*,I'(/.(',%&"'
&.#2*.$(3$"'34,)*.4$"'$%&2.43",'34'(/"'
MJ'.*"',)1,393,347'(/"'$%,(,'B%*'9%$(%*,'
(%'),"'3(:'64'.993(3%4I'34("*4.#',()93",'/.<"'
,/%>4'(/.('(/"3*'$.*93%#%7@',%#)(3%4'$.4'
$)(',/%*('(/"'(3&"'B*%&'KXJ'lK&"*7"4$@'
X"93$.#'J"*<3$",m'(%',)*7"*@'1@')2'(%'e`'
&34)(",I'.49'*"9)$",'(/"'.<"*.7"'(3&"'
,2"4('34'/%,23(.#'B%##%>347'.'/".*('.((.$?'
1@'.#&%,('.'9.@:'
F',$3"4(3+$',()9@'*"2%*("9'34'(/"'J"2("&1"*'
bee'"93(3%4'%B'(/"'Y%)*4.#'%B'(/"'F&"*3$.4'
03.1"(",'F,,%$3.(3%4I',/%>,'(/.('!"##0%$E,'
03.1"(",X.4.7"*®
'9"#3<"*"9'.'e:pa'9"$#34"'
%<"*'.'@".*'34'(/"'?"@'93.1"(",'&"(*3$'
lFeU'5'8#@$.("9'/."&%7#%134mI'$%&2.*"9'
(%'b:da'34'(/"'(",('7*%)2:'!3(/'".$/'ea'
34$*".,"'34'(/"'FeU'#"<"#'*"2*","4(347'.'
s]ba'34$*".,"9'*3,?'%B'&3$*%'.49'&.$*%'
<.,$)#.*'$%&2#3$.(3%4,'B%*'93.1"(",'2.(3"4(,I'
.49'.4'.<"*.7"'&%4(/#@'$%,('%B'%<"*'gcbbI'
*",)#(,',)$/'.,'(/","'&.?"'3('&%*"'#3?"#@'
(/.('2/@,3$3.4'.49'*"7)#.(%*,'>3##'*.239#@'
.9%2('.49'"&1*.$"'(/","',"*<3$",:'
13. Vodafone mHealth Solutions 14
Vodafone mHealth Solutions Insights Guide
V"7)#.(%*@'$%&2#"D3(@I'+4.4$3.#'
$%4,(*.34(,I'"4(*"4$/"9'34B*.,(*)$()*",'
.49'2%%*'34<",(&"4('34'("$/4%#%7@'
$%&134"9'>3(/'.'#.$?'%B')49"*,(.49347'
1@'("$/4%#%7@'2*%<39"*,'/.,'&".4('(/.('
9373(.#'344%<.(3%4'34'/".#(/$.*"'/.,'1""4'
,#%>'(%'(.?"'/%#9:'-%>"<"*I'73<"4'$/.47347'
/".#(/$.*"'4""9,'%B'.4'34$*".,347#@'.7"347'
2%2)#.(3%4'.49'(/"'$/.##"47",'2*","4("9'
1@'(/"'$)**"4('"$%4%&3$'$*3,3,I'(/"*"'
3,'*"4">"9'34("*",('34'(/"'2%("4(3.#'%B'
&-".#(/'.49'64("*4"(',%#)(3%4,'(%'/"#2'
*"9)$"'$%,(,I'34$*".,"'"B+$3"4$3",'
and effectiveness.
C/3,',"$(3%4'$%4,39"*,'(/"'2*.$(3$.#'*".,%4,'
1"/349'(/"',#%>"*'(/.4'"D2"$("9'.9%2(3%4'
of digital health technologies and discusses
"D2"*3"4$",'B*%&'%(/"*',"$(%*,'(/.('$%)#9'
2%("4(3.##@'/"#2'$*".("'>39"',$.#"'.9%2(3%4:
Creating a better customer-centric
experience
M49"*,(.49.1#@'2.(3"4(,'.49'2/@,3$3.4,'
>%)#9'2*"B"*'(%'&.4.7"'/".#(/$.*"'
,"*<3$",'34'.',3&2#"'.49',(*.37/(B%*>.*9'
>.@:'-%>"<"*'&.4@'#3B"',$3"4$"'$%&2.43",'
(%'9.("'/.<"'4%('.$?4%>#"97"9'(/3,'.49'
/.<"'34,(".9',"(')2'.'93,2.*.("',"('%B'
34("*B.$",'>/3$/'.*"'(3*",%&":
F$*%,,'#3B"',$3"4$"'$%&2.43",I'(/"'
9"B.)#('.22*%.$/'(%'%4#34"'34("*.$(3%4'3,'
.',(.49.*9',(.(3$'>"1,3("9
'>/"*"'2*%9)$('
34B%*&.(3%4'$.4'1"'B%)49'34'%4"'2#.$"I'
$%&2.4@'34B%*&.(3%4'34'.4%(/"*I'.49'
(/"*"'3,'4%'%1<3%),'%<"*<3">'%B'(/"'<.#)"=
.99"9',"*<3$",'2*%<39"9:'C/3,'3,'.'/)7"'
&3,,"9'%22%*()43(@:
R"*/.2,'#3B"',$3"4$"'%*7.43,.(3%4,',/%)#9'
#%%?'(%'%(/"*',"$(%*,'B%*'7)39.4$":'
F&.A%4E,'>"1,3("'B%*'"D.&2#"'$.4'73<"'
@%)'.#&%,('.4@(/347'@%)'4""9'>3(/'.'
,347#"',".*$/'B)4$(3%4'.49'.'B">'$#3$?,:'
K<"*@'2)*$/.,"'B%##%>,'(/"'"D.$(',.&"'
,3&2#"'2.(("*4'.49'@%)'9%4E('4""9'(%'
+##'%)('@%)*'2.@&"4('%*'9"#3<"*@'9.(.'.'
,"$%49'(3&":'64'.993(3%4I'F&.A%4'),",'
,%$3.#'*"$%&&"49.(3%4,'.49'2*"93$(3<"'
&.*?"(347'(%'/"#2'@%)'.,'.4'3493<39).#'
(%'+49'(/"'(/347,'@%)'9394E('"<"4'?4%>'
@%)'4""9"9'@"(:';4"'(*),(>%*(/@'2.*(4"*'
(/.('?4%>,'@%)*'2*"B"*"4$",'.49',)22%*(,'
@%)'.$$%*9347#@I'.'9*".&'$%&"'(*)":::'
,%'>/@'.*"'#3B"',$3"4$",'$%&2.43",'4%('
"&1*.$347'(/3,^
F9&3(("9#@I'(/"'349),(*@'3,'#".*4347'5'1)('
,#%>#@:'C.?"'B%*'"D.&2#"'(/"'MJ'1.,"9'
9373(.#'/".#(/$.*"'2%*(.#'-".#(/8*.9",:'
6('/"#2,'2.(3"4(,'+49'9%$(%*,'.$$%*9347'
(%'(/"3*'4""9:'f"(E,',.@'@%)'4""9'(%'+49'
.'$.*93%#%73,('$#%,"'(%'G">'k%*?I'(/"4'
@%)'$.4'+49'&%*"'(/.4'`bb'2%,,31#"'Gk'
$.*93%#%73,(,'%4'(/3,'2%*(.#:'-%>'9%'@%)'
?4%>'>/3$/'2/@,3$3.4'>3##'2*%<39"'(/"'
1",('$.*"^'C/*%)7/'/37/=<%#)&"'2.(3"4('
*.(347,I'(/"'2/@,3$3.4,'.*"'*.4?"9'
$%4<"43"4(#@'.49'@%)'$.4'3&&"93.("#@'
+49'(/"'2/@,3$3.4'%B'@%)*'$/%3$":'
)"*%+",%$-./*"0,.1(",.2"$"#&
SC/"'#.,('(>"4(@'@".*,'>"*"'.1%)('
1"$%&347'9373(.#I'(/"'4"D('(>"4(@'@".*,'
>3##'1"'.1%)('1"$%&347'$#"<"*'>3(/'9373(.#TI'
,.@,'U/.3*&.4'%B'F$*%,,'C"$/4%#%7@I'R"("*'
-34,,"4:'C/3,'&37/(',%)49'(*3("'1)('34'%*9"*'
(%'),"'("$/4%#%7@'$),(%&"*,'&),('+*,('
By Fonny Schenck,
UK;'.('F$*%,,'-".#(/I'.4'
international management
$%4,)#(.4$@'B%*'9373(.#'
innovation in life sciences
Adopting technology:
understanding the challenges
for healthcare professionals
14. Vodafone mHealth Solutions 15
Vodafone mHealth Solutions Insights Guide
)49"*,(.49'3(,'1"4"+(,:'649""9'34'.'>.@'
("$/4%#%73,(,'/.<"'1""4'93,(*.$("9'1@'(/"'
$%4$"2('%B'("$/4%#%7@'5'.49'34,(".9'%B'
>%*?347'(%>.*9,'1"(("*',"*<3$",'/.<"',2"4('
(%%'&)$/'(3&"'(*@347'(%'1)3#9'.'$#"<"*"*'
,@,("&:'F3*J(*32'UK;'F#.4'R%*("#.'"D2#.34"9'
(/3,'34'(/"'$%4("D('%B'K#"$(*%43$'X"93$.#'
V"$%*9,I'KXV,L'SKXV,'.*"'2#.(B%*&,I'C/"'
,.&"'>.@'(/.('@%)*'$%&2)("*'/.,'.4'
t%2"*.(347',@,("&u'5'KXV,'.*"'(/"';J:'
k%)'1"4"+('B*%&'(/"'.22,'(/.('@%)'2)('%4'
(%2'%B'(/"';JI'>/3#"'@%)'9%4E('1"4"+(',%'
much from the OSeb
:T';B'$%)*,"'>3(/%)('
(/"';2"*.(347'J@,("&'(/"'.22,'>%)#9'4%('
>%*?'1)(',(3##I'(/"'2%34('4""9,'(%'1"'&.9":'
&-".#(/'("$/4%#%7@'2*%<39"*,'>%)#9'9%'
>"##'(%'1".*'(/3,'34'&349'>/"4'$%4,39"*347'
2*%9)$('344%<.(3%4,:
Right place, right technology, right
doctor and right patient
64'(/"'B)()*"'/".#(/$.*"'>3##'1"'9"#3<"*"9'
through a multitude of channels and it
3,'$#".*'(/.('&%13#"'9"<3$",'>3##'/.<"'.'
93,(34$('*%#"'(%'2#.@'34'(/3,:'W)('&%13#"'
9"<3$",'.*"'4%('(/"'%4#@'%2(3%4I'%(/"*'
9"<3$",'%*'$/.44"#,',/%)#9'.49'>3##'1"'
),"9'>/"4'&%*"'.22*%2*3.(":
G%('%4#@'9%'$"*(.34'9"<3$",'+('$"*(.34'
$%4("D(,'1"(("*I'(/"',"*<3$",'2*%<39"9'
on these devices should integrate as
,".&#",,#@'.,'2%,,31#"'>3(/'(/"'4%*&.#'
>%*?'2.(("*4,'%B'(/"'/".#(/$.*"'2*%B",,3%4.#'
.49'2.(3"4(:'P.3#)*"'(%'.$/3"<"'(/3,'/.,'34'
(/"'2.,('#"9'(%',3743+$.4('+4.4$3.#'
34<",(&"4('>3(/%)('.4@'&.("*3.#'7.34:
mHealth technologists need to consider
/%>'1",('(%'+('(/"3*',"*<3$"'34(%'(/"'
2.(3"4(,E'9.3#@'#3<",'%*'(/"'2/@,3$3.4,E'
4%*&.#'>%*?i%>:'C/"'?"@'Q)",(3%4'(/"@'
,/%)#9'.,?'3,'/%>'$.4'>"'&.?"'(/"3*'#3<",'
".,3"*I'.49'4%('&%*"'93B+$)#(^'
Understanding pricing and
reimbursement dynamics
C/"'34("*4"('/.,'*.93$.##@'(*.4,B%*&"9'
2*3$347'&%9"#,'.49'&.4@'%*7.43,.(3%4,'
.*"'1.((#347'(%'.9.2('(%'(/3,:'64$*".,347#@'
SB*""&3)&T'&%9"#,'$%&134"9'>3(/'
advertising have great success. There
.*"'.##',%*(,'%B'>.@,'%B'.9%2(347'.'
B*""&3)&'.22*%.$/:'P%*'"D.&2#"I'34'/3,'
1%%?'SP*""L'(/"'P)()*"'%B'.'V.93$.#'R*3$"T'
U/*3,'F49"*,%4'9",$*31",'/%>'2*.$(3$"'
&.4.7"&"4(',%B(>.*"'3,'73<"4'.>.@'1@'
(/"'U.#3B%*43.4'$%&2.4@'R*.$(3$"'P),3%4:'
C/"'2/@,3$3.4,'.*"'73<"4'(/"'B*""'<"*,3%4'%B'
(/"',%B(>.*"'>3(/'.9,'%*'$.4'1)@'.4'.9=B*""'
<"*,3%4'B%*'ebb'MJ0'2"*'&%4(/:'F993(3%4.#'
<.#)"'3,'$*".("9'1@',"##347'.4%43&3,"9'
2.(3"4('$/.*(,'(%'&"93$.#'.,,%$3.(3%4,'
B%*'*",".*$/'2)*2%,",:'ebbIbbb'&"93$.#'
2*%B",,3%4.#,'.*"'$)**"4(#@'),347'(/"'
,"*<3$"'.49'(/"'4)&1"*'3,'7*%>347I'>3(/'
c`b'4">'),"*,'"<"*@'9.@11
.
J(.49.*9'/".#(/$.*"'2*.$(3$"'3,'
,%&">/.('93BB"*"4('(%'(/3,:'64'9"<"#%2"9'
"$%4%&3",'$%&&%4'2*.$(3$"'3,'(%'*"#@'%4'
*"3&1)*,"&"4('B*%&'(/"'7%<"*4&"4(I'34'
>/3$/'$.,"'(/"'("$/4%#%7@'3,'$%4,39"*"9'
l4".*#@m'B*""'B%*'(/"'"49'),"*:'64'&%,('
$%)4(*3",I'9%$(%*,'.*"'2.39'1.,"9'%4'(/"'
4)&1"*'%B'2.(3"4(,'(/"@'(*".('%*'&""('
in the consulting room. If doctors are
*">.*9"9'34'(/3,'>.@'3('3,'<"*@'$#".*'>/@'
(/"@'.*"'*"(3$"4('34'.9%2(347'("$/4%#%73",'
(/.('*"9)$"'B.$"=(%=B.$"'34("*.$(3%4,:'P*%&'
(/.('2"*,2"$(3<"I'349""9L'!/.('(%'(/"&'3,'
(/"'1"4"+('%B'*"&%("'&%43(%*347^'
An interesting recent initiative from
F),(*.#3.')49"*,$%*",'(/"'3&2%*(.4$"'
%B'*"3&1)*,"&"4(h34$"4(3<",'34'(/"'
.9%2(3%4'%B'4">'("$/4%#%73",L',34$"'
j)#@'bee'.49'B%*'(/"'4"D('B%)*'@".*,I'
(/"'F),(*.#3.4'7%<"*4&"4('3,'.$(3<"#@'
2*%&%(347'("#"/".#(/'1@'2*%<39347'1%4),",'
(%'/".#(/$.*"'2*%B",,3%4.#,'(/.('.9%2('
("#"/".#(/'("$/4%#%7@'.49'(/.('2.*(3$32.("'
34'<39"%=$%4,)#(,'>3(/'2.(3"4(,:
U*%,,347'(/"'l&-".#(/m'$/.,&
8"%BB*"@'F:'X%%*"E,'1%%?'SU*%,,347'(/"'U/.,&T'9",$*31",'(/"'7*".(",('
93B+$)#(@'(/.('&.4@'93,*)2(3<"'("$/4%#%73$.#'344%<.(3%4,'B.$"'34'$*%,,347'
(/"'$/.,&'1"(>""4'344%<.(%*,'.49'".*#@'.9%2("*,:'6('3,'$#".*'(/.('(/"'
2*3%*3(3",'%B'9%$(%*,'.49'/".#(/$.*"'>%*?"*,'.*"'<"*@'93BB"*"4('B*%&'(/.('
%B'(/"'("$/4%#%73,(:'C/"'1",(',(3&)#),'(%'(/"'.9%2(3%4'%B'&-".#(/'3,'(%'
()*4'(/"'.1%<"'/)*9#",'34(%'9*3<"*,L'2)((347'(/"'$),(%&"*'.('(/"'/".*('%B'
@%)*'1),34",,I'%BB"*347')4,)*2.,,"9'),"*'1"4"+(,I'9",374347'B%*'(/"'*37/('
),"'$%4("D(I'.49'%BB"*347'.4'.((*.$(3<"'2*3$347'&%9"#:
15. Vodafone mHealth Solutions 16
Vodafone mHealth Solutions Insights Guide
Understanding health
psychology and the
science of behaviour
Introduction
-.<347'"<.#).("9'.'4)&1"*'%B'&-".#(/'
,"*<3$",'%4'(/"'1.,3,'%B',)$$",,'34'),"*'
.9%2(3%4I'(/3,'#.,(',"$(3%4'%B'(/"'*"2%*('
.3&,'(%'$%4("D().#3,"'(/"'$)**"4(',(.("'
of mHealth through relevant academic
#3("*.()*"'%4'),"*'.9%2(3%4'1"/.<3%)*:
C/"*"'3,'.'7*%>347'$%*2),'%B'#3("*.()*"'
9%$)&"4(347'(/"'9"<"#%2&"4('%B'93BB"*"4('
mHealth technologies. Alongside technical
.,2"$(,I'93,$),,3%4,'"D2#%*"'3,,)",'%B'
93,,"&34.(3%4'.49'3&2#"&"4(.(3%4I'.49'
(/"*"'/.<"'1""4'.'4)&1"*'%B'2*"#3&34.*@'
"<.#).(3%4,'34'("*&,'%B'3&2.$('%4'/".#(/'
%)($%&",I'2.(3"4(',.(3,B.$(3%4'.49'
1"/.<3%)*'$/.47":'!/.('3,'#.*7"#@'.1,"4('
B*%&'(/"'2)1#3,/"9'#3("*.()*"I'/%>"<"*I'
3,'*37%*%),'*",".*$/'%4'(/"'2*%$",,'%B'
)2(.?"'.49'.9%2(3%4'%B'&-".#(/'B*%&'
(/"'2"*,2"$(3<"'%B'1%(/'(/"'2.(3"4('.49'
/".#(/$.*"'2*%<39"*:'64'(/3,',"$(3%4I'
(/"*"B%*"I'>"'.99*",,'(>%'&.34'Q)",(3%4,L
N''!/.('"D3,(347'(/"%*3",'.49'*",".*$/'$.4'
1"'),"9'(%'"D2#.34'.9%2(3%4'1"/.<3%)*'%B'
("$/4%#%73",'%B'/".#(/^'
N''!/.('$%4,(3()("'(/"'&.34'1.**3"*,'(%'
&-".#(/'.9%2(3%4^
Existing theories
-".#(/=*"#.("9'1"/.<3%)*'3,'/37/#@'$%&2#"D'
and efforts to understand and account
B%*'3493<39).#'.49'$%##"$(3<"'1"/.<3%)*'
and its determinants continue across
&)#(32#"'93,$32#34",:'0*.>347'%4'(/"%*"(3$.#'
B*.&">%*?,'B*%&'.4(/*%2%#%7@I'/".#(/'
2,@$/%#%7@I',%$3%#%7@'.49'$)#()*.#'
"239"&3%#%7@I'(/"'B%##%>347'2*","4(,'.'1*3"B'
%)(#34"'%B',"#"$("9'(/"%*3",'%B'1"/.<3%)*'
.,'(/"@'*"#.("'(%'/".#(/$.*"'2*.$(3$",'.49'
/".#(/',@,("&'*",2%4,":
The Health Belief Model
P3*,('9"<"#%2"9'34'(/"'ep`b,'1@',%$3.#'
2,@$/%#%73,(,'-%$/1.)&I'V%,"4,(%$?'.49'
["7"#,eIec
I'(/3,'&%9"#'.(("&2(,'(%'"D2#.34'
.49'2*"93$('/".#(/'1"/.<3%)*,'1@'B%$),347'
%4'(/"'.((3()9",'.49'1"#3"B,'%B'3493<39).#,:'
C/"'&%9"#'3,',(*)$()*"9'.*%)49'B%)*'?"@'
$%4$"2(,'>/3$/'.$$%)4('B%*'.4'3493<39).#E,'
*".934",,'(%'.$(L
N'2"*$"3<"9',),$"2(313#3(@'
N'2"*$"3<"9',"<"*3(@'
N'2"*$"3<"9'1"4"+(,'
N'2"*$"3<"9'1.**3"*,
F993(3%4.#'$%4$"2(,I'$)",'(%'.$(3%4'
.49',"#B="B+$.$@I'>"*"'#.("*'.99"9'(%'
/"#2'(/"'-".#(/'W"#3"B'X%9"#'.99*",,'
/.13().##@')4/".#(/@'1"/.<3%)*,',)$/'.,'
,&%?347I'%<"*".(347'.49'1"347',"9"4(.*@'
l$%493(3%4,'(/.('&-".#(/'("$/4%#%73",'
/.<"'.99*",,"9m:'W"#3"B'.49'/".#(/'
&%(3<.(3%4'.*"',""4'(%'1"'$%493(3%4"9'
1@',%$3%=9"&%7*.2/3$'<.*3.1#",'.49'
(/"'2,@$/%#%73$.#'$/.*.$("*3,(3$,'%B'
(/"'3493<39).#:'C/"'&%9"#'/.,'1""4'
),"9'"D("4,3<"#@'34'9"("*&34347'/".#(/'
2*%&%(3%4'.$(3<3(3",14
:'-%>"<"*I'3('B.3#,'(%'
34$%*2%*.("'B".()*",',)$/'.,'(/"'34i)"4$"'
%B'2*"<3%),'"D2"*3"4$"I'.9<.4(.7",'%B'&.#=
.9.2(3<"'1"/.<3%)*I'1"/.<3%)*.#'34("4(3%4'
.49'2"*$"3<"9'$%4(*%#:
By Dr Juliet BedfordI'P%)49"*'.49'03*"$(%*'%B'F4(/*%#%73$.I'
.'*",".*$/'1.,"9'$%4,)#(.4$@'+*&',2"$3.#3,347'34'(/"'
.22#3"9'.4(/*%2%#%7@'%B'/".#(/$.*"
16. Vodafone mHealth Solutions 17
Vodafone mHealth Solutions Insights Guide
Theory of Planned Behaviour
F4'"D("4,3%4'%B'(/"'C/"%*@'%B'V".,%4"9'
F$(3%4I'B%*&)#.("9'1@'FYA"4'.49'P3,/1"34'
34'epnb15
I'>/3$/',%)7/('(%'",(3&.("'
(/"'93,$*"2.4$@'1"(>""4'.((3()9"'
.49'1"/.<3%)*I'(/"'C/"%*@'%B'R#.44"9'
W"/.<3%)*'l.#,%',""'+7)*"'m16
'2*"93$(,'
9"#31"*.("'1"/.<3%)*.#'34("4(3%4'),347'
(/*""'$%4,(*)$(,L'1"/.<3%)*.#'1"#3"B,I'
4%*&.(3<"'1"#3"B,'.49'$%4(*%#'1"#3"B,:'
N''W"/.<3%)*.#'1"#3"B,'l.((3()9",'(%>.*9,'
(/"'1"/.<3%)*m'.*"'9"("*&34"9'1@'(/"'
4%(3%4'(/.('.',2"$3+$'1"/.<3%)*'>3##'/.<"'
a concrete consequence.
N''G%*&.(3<"'1"#3"B,'l(/"',)1Y"$(3<"'4%*&m'
.*"'$%4$"*4"9'>3(/'<3">,'.1%)('/%>'
2"%2#"'5'(/"'3493<39).#E,',%$3.#'4"(>%*?'
5'>3##'*"7.*9'(/"'1"/.<3%)*'34'Q)",(3%4I'
2#),'2"*,%4.#'&%(3<.(3%4'(%'B)#+#'(/"'
"D2"$(.(3%4'%B'%(/"*,:'
N''U%4(*%#'1"#3"B,'l2"*$"3<"9'1"/.<3%)*.#'
$%4(*%#m'*"B"*'(%'.4'3493<39).#E,'
2"*$"2(3%4'%B'(/"3*'.13#3(@'(%'2"*B%*&'.'
73<"4'1"/.<3%)*I'1"#3"B'.1%)('.$$",,'(%'
the resources needed in order to
.$(',)$$",,B)##@:'
C/","'2*"93$(%*,'#".9'(%'34("4(3%4I'(/"'
2*"$)*,%*'%B'1"/.<3%)*:'64'7"4"*.#I'(/"'
&%*"'B.<%)*.1#"'(/"'.((3()9"'.49'(/"'
,)1Y"$(3<"'4%*&I'(/"'7*".("*'(/"'2"*$"3<"9'
$%4(*%#I'(/"',(*%47"*'.'2"*,%4E,'34("4(3%4'
(%'2"*B%*&'(/"'1"/.<3%)*'34'Q)",(3%4:'C/"'
.9<.4(.7"'%B'(/"'2*.$(3$.#'.22#3$.(3%4'%B'
(/3,'(/"%*@'3,'(/.('3('(.?",'34(%'.$$%)4('
&%(3<.(3%4.#'.,2"$(,'%B'2"*,%4.#'$%4(*%#'
.49'(/"'34i)"4$"'%B',%$3.#'4"(>%*?,I'1)('
3('$.4'1"'#3&3("9'1@'.4'%<"*="&2/.,3,'%B'
2,@$/%#%73$.#'B.$(%*,'>/3#,(')49"*=<.#)347'
structural forces such as the reduced
.<.3#.13#3(@'%B'*",%)*$",'%*'2%%*'.$$",,:
Healthcare Utilisation Model
0"<"#%2"9'1@'F49"*,%4'.49'G">&.417
34'(/"'epdb,I'(/3,',%$3%=1"/.<3%)*.#'
&%9"#'7*%)2,'(/*""'$#),("*,'%B'B.$(%*,'
(/.('$.4'34i)"4$"'/".#(/'1"/.<3%)*'34'.'
#%73$',"Q)"4$"L'
N'2*"93,2%,347
N'"4.1#347'
N need factors
C/3,'&%9"#'>.,'9"<"#%2"9'(%'34<",(37.("'
(/"'),"'%B'13%&"93$.#'/".#(/',"*<3$",I'
.#(/%)7/'#.("*'<"*,3%4,'>"*"'"D("49"9'
to include other healthcare sectors18
.
6('$"4(*",',2"$3+$.##@'%4'(*".(&"4('
,"#"$(3%4'.49'34$#)9",'1%(/'&.("*3.#'
.49'#%73,(3$.#'B.$(%*,'(/.('.*"'4%('B)##@'
.$$%)4("9'B%*'34'%(/"*'&%9"#,:'[*%"7"*19
"#.1%*.("9'(/"'&%9"#'(%'34$#)9"'/".#(/'
,"*<3$"',@,("&'B.$(%*,I'*"B"**347'(%'(/"'
,(*)$()*"'%B'(/"'/".#(/$.*"',@,("&'.49'3(,'
#34?'(%'(/"',%$3%=2%#3(3$.#'&.$*%="$%4%&@'
34'>/3$/'3('%2"*.(",:'C/"'.9<.4(.7"'%B'
,%$3%=1"/.<3%)*.#'&%9"#,'3,'(/"'<.*3"(@'
%B'B.$(%*,I'%*7.43,"9'34(%'$.("7%*3",I'
(/.('&.?"'34("*<"4(3%4,'B%*'(/"*.2")(3$'
.$(3%4'l%*'#.$?'%B'3(m'B".,31#":'6('2"*&3(,'(/"'
",(.1#3,/&"4('%B'$%**"#.(3%4,'>3(/'7%%9'
2*"93$(.13#3(@I'1)('4%(',2"$3+$.(3%4'%B'
/%>'.49'>/@'(/"'93BB"*"4('B.$(%*,'.BB"$('
(/"*.2")(3$',"#"$(3%4:
Behavioural
attitude
Subjective
norms
Perceived
behavioural
control
Intention Behaviour
Figure 2 Theory of Planned Behaviour
17. Vodafone mHealth Solutions 18
Vodafone mHealth Solutions Insights Guide
Social Cognitive Theory
P*%&'(/"'ep_b,'%4>.*9,I'W.49)*.b'
has
9"<"#%2"9',%$3.#'$%743(3<"'(/"%*@'(%'
"D2#.34'/%>'2"%2#"'.$Q)3*"'.49'&.34(.34'
$"*(.34'1"/.<3%)*.#'2.(("*4,:'W.,"9'%4'
(/"'".*#3"*'C/"%*@'%B'J%$3.#'f".*4347e'
(/*""'9%&34.4('B.$(%*,'>"*"',""4'(%'
1"'$%4,(.4(#@'34i)"4$347'".$/'%(/"*L'
"4<3*%4&"4('l,%$3.#'.49'2/@,3$.#mI'
2"%2#"'.49'1"/.<3%)*:'
Bandura suggested that individuals are
$.2.1#"'%B'#".*4347'4%('Y),('B*%&'(/"3*'%>4'
"D2"*3"4$",I'1)('<3$.*3%),#@I'B*%&'(/%,"'
.*%)49'(/"&:'[4%>4'.,';1,"*<.(3%4.#'
f".*4347I'(/"'2*%$",,'3,'*"7)#.("9'1@'B%)*'
,)1'B)4$(3%4,L'
N'.(("4(3%4.#'2*%$",,",'
N'*"("4(3%4'2*%$",,",'
N'2*%9)$(3%4'2*%$",,",'
N'&%(3<.(3%4.#'2*%$",,",'
f34?"9'(%'(/3,'3,',"#B="B+$.$@'l1"/.<3%)*.#'
$.2.13#3(@mI'(/"'Z1"#3"B,'34'%4"E,'$.2.13#3(3",'
(%'%*7.43,"'.49'"D"$)("'(/"'$%)*,",'
%B'.$(3%4'*"Q)3*"9'(%'2*%9)$"'73<"4'
.((.34&"4(,E
:'J%$3.#'U%743(3<"'C/"%*@'
3,'),"9'"D("4,3<"#@'34'(/"'9",374'%B'
/".#(/'"9)$.(3%4'.49'/".#(/'1"/.<3%)*'
2*%7*.&&",'.49'.,'(/"'1.,3,'B%*'
intervention strategies.
Other theoretical considerations
[#"34&.4E,'$%4$"2('%B'KD2#.4.(%*@'
X%9"#,c
'$%4(.34'"D2#.4.(3%4,'%B'."(3%#%7@I'
%4,"('%B',@&2(%&,I'2.(/%2/@,3%#%7@I'
$%)*,"'%B',3$?4",,'.49'(*".(&"4(I'(%'
"#.1%*.("'Z,2"$3+$',@,("&,'%B'?4%>#"97"'
and values centred in the different social
,"$(%*,'.49',)1=,"$(%*,'%B'(/"'/".#(/$.*"'
,@,("&E]
:'64'2%#3(3$.#="$%4%&3",'%B'
/".#(/I'B.$(%*,'$.("7%*3,347'.<.3#.13#3(@I'
.$$",,313#3(@I'.BB%*9.13#3(@'.49'.$$"2(.13#3(@'
still dominate.
X.4@'&%9"#,'.,,)&"'(/.('3493<39).#,'
"47.7"'34'.'*.(3%4.#'2*%$",,'%B'>"37/347'
(/"'1"4"+(,'.49'$%,(,'%B'1"/.<3%)*.#'
choices and select the course of action
>3(/'(/"'&%,('B.<%)*.1#"'$%,(=1"4"+('
*.(3%'l.,'34'(/"'-".#(/'W"#3"B'X%9"#I'(/"'
C/"%*@'%B'R#.44"9'W"/.<3%)*I'.49'(/"'
J%$3.#'U%743(3<"'C/"%*@mI'1)('.BB"$(3<"'
associations`
'/.<"'.#,%'1""4',/%>4'(%'
1"'34i)"4(3.#:'M4#3?"'(/","'Z$%4(34))&E'
(/"%*3",'l>/3$/'2#.$"'.4'3493<39).#'.#%47'
.'$%4(34))&'%B'.$(3%4'#3?"#3/%%9mI'Z,(.7"9E'
(/"%*3",I',)$/'.,'(/"'C*.4,(/"%*"(3$.#'
X%9"#'%B'W"/.<3%)*'U/.47"'l.#,%',""'
+7)*"'cm_
'/.<"'.*3,"4'B*%&'9%)1('(/.('
#34".*'&%9"#,'.*"'B)##@'$.2.1#"'%B'$.2()*347'
(/"'$%&2#"D'2*%$",,",'(/.(')49"*#3"'
9"$3,3%4,'(%'"47.7"'34'/".#(/'1"/.<3%)*,d
.
69".##@I'.,'-.),&.44=X)"#.'$%4$#)9",I'
Z.'$%4("D().#3,"9'.4.#@,3,'%B'/".#(/'
1"/.<3%)*,',/%)#9'l.m'1"'4"$",,.*3#@'
34("*93,$32#34.*@I'$%&134347'Z4.()*.#'
,$3"4$",E'>3(/'Z,%$3.#',$3"4$",E'.22*%.$/",O'
l1m'4%('B.3#'(%'$%4,39"*'(/.('(/"',()93"9'
Z$%4("D(,E'.*"'2.*('%B'.'/3,(%*3$.#'2*%$",,O'
l$m'$%&134"'Z&3$*%E'>3(/'Z&.$*%E'#"<"#,O'.49'
l9m'(*3.47)#.("'Q).#3(.(3<"'.49'Q).4(3(.(3<"'
34<",(37.(3%4'("$/43Q)",En
.
C%')49"*,(.49'1"/.<3%)*'.,,%$3.("9'>3(/'
(/"'.9%2(3%4'%B'("$/4%#%73",'%B'/".#(/I'
>"'4""9'(%'%<"*#.@'(/"%*3",'9"*3<"9'B*%&'
,%$3.#'.49'1"/.<3%)*.#',$3"4$"I'>3(/'
(/"%*3",'%B'),"*'"47.7"&"4('9*.>4'B*%&'
(/"'+"#9,'%B'64B%*&.(3%4'U%&&)43$.(3%4'
.49'C"$/4%#%7@:
Stage 4: ACTION
Dedicates considerable
time and energy; make
overt and viable changes;
developes strategies to
deal with barriers
Stage 3:
PREPARATION
Intends to take action
and makes small changes;
needs to set goals
and priorities
Stage 2:
CONTEMPLATION
Aware the problem exists
and serious evaluation
of options but not
committed to
take action
Stage 1:
No intention to
change, often unaware
of the problem
Stage 6:
EVALUATION
Assessment and feedback
to continue dynamic
change process
Stage 5:
ADAPTATION /
MAINTENANCE
Works to adapt and adjust
to facilitate maintenance
of change
PRE-CONTEMPLATION
Figure 3 Transtheoretical Model of Behaviour Change
18. Vodafone mHealth Solutions 19
Vodafone mHealth Solutions Insights Guide
Diffusion of Innovations Theory
V%7"*,E'03BB),3%4'%B'644%<.(3%4,'
C/"%*@'l.#,%',""'+7)*"']mp
is the most
34i)"4(3.#'34')49"*,(.49347'/%>'.4'
344%<.(3%4'34+#(*.(",'.'2%2)#.(3%4'l%*'4%(mI'
.49'2*%<39",'.'$%&2*"/"4,3<"',(*)$()*"'
B%*')49"*,(.49347'3493<39).#'.9%2(3%4'.49I'
$%##"$(3<"#@I'93BB),3%4:'6('B%$),",'%4'(/"'
conditions that increase or decrease the
#3?"#3/%%9'%B'.'4">'39".I'2*%9)$('%*'
2*.$(3$"'1"347'.9%2("9:'
V%7"*,'2*","4("9'B%)*',(.7",L'
(/"'344%<.(3%4'3(,"#BO'93BB),3%4'l%*'
$%&&)43$.(3%4m'(/*%)7/'(/"',%$3.#',@,("&O'
(3&"O'.49'$%4,"Q)"4$",:'-"'.*7)"9'(/.('
.4'344%<.(3%4'3,'Z.4'39".I'2*.$(3$"I'%*'%1Y"$('
(/.('3,'2"*$"3<"9'(%'1"'4">'1@'.4'3493<39).#'
%*'%(/"*')43('%B'.9%2(3%4EI'93BB),3%4'3,'
Z(/"'Z2*%$",,'1@'>/3$/'.4'344%<.(3%4'3,'
communicated through certain channels
%<"*'.'2"*3%9'%B'(3&"'.&%47'(/"'&"&1"*,'
%B'.',%$3.#',@,("&EI'.49'$%&&)43$.(3%4'3,'
Z(/"'2*%$",,'34'>/3$/'2.*(3$32.4(,'$*".("'
.49',/.*"'34B%*&.(3%4'>3(/'%4"'.4%(/"*'
(%'*".$/'.'&)().#')49"*,(.49347E:'
C/"'(/"%*@',)77",(,'(/.('1"$.),"'
34B%*&.(3%4'i%>,'(/*%)7/'4"(>%*?,I'
%2343%4'#".9"*,'34'(/.('4"(>%*?'2#.@'.'
*%#"'34'9"("*&34347'(/"'#3?"#3/%%9'(/.('
(/"'344%<.(3%4'>3##'1"'.9%2("9I'1)('
.993(3%4.#'34("*&"93.*3",'l$/.47"'.7"4(,'
.49'7.("?""2"*,m'.*"'.#,%'34i)"4(3.#:'
P3<"'$.("7%*3",'%B'.9%2("*'.*"'%)(#34"9'
>/3$/'B%##%>'.4'J=,/.2"9'93BB),3%4'$)*<"L'
344%<.(%*,I'".*#@'.9%2("*,I'".*#@'&.Y%*3(@I'
#.("'&.Y%*3(@I'.49'#.77.*9,:'
03BB),3%4'*",".*$/'/.,'B%$),"9'%4'+<"'
&.34'"#"&"4(,L'(/"'$/.*.$("*3,(3$,'%B'
.4'344%<.(3%4'>/3$/'&.@'34i)"4$"'3(,'
.9%2(3%4O'(/"'9"$3,3%4=&.?347'2*%$",,'
(/.('%$$)*,'>/"4'3493<39).#,'$%4,39"*'
(/"'.9%2(3%4O'(/"'$/.*.$("*3,(3$,'%B'
3493<39).#,'(/.('&.?"'(/"&'#3?"#@'(%'.9%2('
.4'344%<.(3%4O'(/"'$%4,"Q)"4$",'B%*'
3493<39).#,'.49',%$3"(@'%B'.9%2(347'(/"'
344%<.(3%4O'.49'$%&&)43$.(3%4'$/.44"#,'
),"9'34'(/"'.9%2(3%4'2*%$",,:'U#%,"#@'
#34?"9'(%'03BB),3%4'%B'644%<.(3%4,'C/"%*@'
3,'G"(>%*?'F4.#@,3,'.49'J%$3.#'G"(>%*?'
C/"%*@cb
'.49'U*3(3$.#'X.,,'C/"%*@31
.
0
100
75
50
25
Marketshare%
Innovators
2.5%
Early
Adopters
13.5%
Early
Majority
34%
Late
Majority
34%
Laggards
16%
Figure 4 Diffusion of Innovations Theory
X.*?"('2"4"(*.(3%4
f"<"#'%B'.9%2(3%4
19. ''H%9.B%4"'&-".#(/'J%#)(3%4,''b
Vodafone mHealth Solutions Insights Guide
Technology Acceptance Model
C/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'3,'
%4"'%B'(/"'&%,('34i)"4(3.#'"D("4,3%4,'
%B'FYA"4E,'C/"%*@'%B'V".,%4"9'F$(3%4'.49'
C/"%*@'%B'R#.44"9'W"/.<3%)*:'0"<"#%2"9'1@'
0.<3,cI'cc
'3('3,'.4'34B%*&.(3%4',@,("&,'(/"%*@'
(/.('&%9"#,'/%>'),"*,'$%&"'(%'.$$"2('.49'
),"'.'("$/4%#%7@:'6('*"2#.$",'FYA"4E,'.((3()9"'
&".,)*",'>3(/'(>%'("$/4%#%7@'.$$"2(.4$"'
&".,)*",L'2"*$"3<"9'),"B)#4",,'l(/"'9"7*""'
(%'>/3$/'.'2"*,%4'1"#3"<",'(/.('),347'.'
2.*(3$)#.*',@,("&'>%)#9'"4/.4$"'/3,'%*'/"*'
Y%1'2"*B%*&.4$"mI'.49'2"*$"3<"9'".,"=%B=
),"'l(/"'9"7*""'(%'>/3$/'.'2"*,%4'1"#3"<",'
(/.('),347'.'2.*(3$)#.*',@,("&'>%)#9'1"'
B*""'B*%&'"BB%*(m:'C/"'&%9"#'.,,)&",'(/.('
>/"4',%&"%4"'B%*&,'.4'34("4(3%4'(%'.$(I'
(/"@'>3##'1"'B*""'(%'.$('>3(/%)('#3&3(.(3%4I'
>/"*".,'34'(/"'*".#'>%*#9I'(/"*"'>3##'1"'
<.*3%),'$%4,(*.34(,:';(/"*'&%9"#,'"D2#.34347'
.$$"2(.4$"'2"*$"2(3%4,'.49'1"/.<3%)*,'
.,,%$3.("9'>3(/'64B%*&.(3%4'C"$/4%#%7@'
34$#)9"'U%&2)("*'J"#B=KB+$.$@34
I'C.,?=
C"$/4%#%7@'P3(35
'.49'(/"'X%(3<.(3%4.#'
X%9"#36
.
United Theory of Acceptance and Use
'3.4"/5$'*'-6.7.8$%#"!.45"',6.'3.
Consumer Acceptance Technology
Recent studies have sought to integrate
,%&"'%B'(/"'2*3%*'&%9"#,:'H"4?.(",/37
"D.&34"9'"37/('%B'(/"'&%,('$%&&%4'
(/"%*"(3$.#'B*.&">%*?,'.49'&%9"#,'),"9'
(%'"D2#.34'3493<39).#'.9%2(3%4'.49'),"'%B'
("$/4%#%7@'.49'1*%)7/('(%7"(/"*'(/"3*'
&%,(',.#3"4('$/.*.$("*3,(3$,'(%'B%*&'.')43+"9'
(/"%*@I'M43("9'C/"%*@'%B'F$$"2(.4$"'.49'
M,"'%B'C"$/4%#%7@'l.#,%',""'+7)*"'`m:'
C/3,'2*","4(,'B%)*'?"@'9"("*&34.4(,'%B'),"'
l2"*B%*&.4$"'"D2"$(.4$@I'"BB%*('"D2"$(.4$@I'
,%$3.#'34i)"4$"'.49'B.$3#3(.(347'$%493(3%4,m'
and four moderators of individual use
l7"49"*I'.7"I'"D2"*3"4$"'.49'<%#)4(.*34",,m:'
J3&3#.*#@I'[)#<3>.(38
designed the Consumer
F$$"2(.4$"'%B'C"$/4%#%7@'B*.&">%*?'1@'
&"*7347'(>%'2*"<3%),#@')4*"#.("9'&%9"#,I'
(/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'.49'
(/"'R#".,)*"I'F*%),.#'.49'0%&34.4$"'
2.*.937&'%B'.BB"$('l9"<"#%2"9'.,'.'&%9"#'34'
"4<3*%4&"4(.#=2,@$/%#%7@'1@'X"/*.1.3439
I'
3(',)77",(,'(/.('.##'"&%(3%4.#'*",2%4,",'(%'
2/@,3$.#'.49',%$3.#'"4<3*%4&"4(,'$.4'1"'
$.2()*"9'>3(/'(/*""'93&"4,3%4,'%B'.BB"$(L'
2#".,)*"I'.*%),.#'.49'9%&34.4$"m:'
Sun and Zhang]b
'2*","4('.',@,("&.(3$'
.4.#@,3,'%B'(/"'"D2#.4.(%*@'.49',3().(3%4.#'
#3&3(.(3%4,'%B'"D3,(347'("$/4%#%7@'
.$$"2(.4$"',()93",:'C/"@'$.##'B%*'&%*"'
*",".*$/'34(%'(/"'3493<39).#'.49'$%4("D().#'
factors that are often neglected in
("$/4%#%7@'.$$"2(.4$"',()93",'1)('$.4'
1"'$*3(3$.#'34'(/"'.22#3$.(3%4'%B'(/"'
(/"%*"(3$.#'&%9"#,I'.49'39"4(3B@'("4'
&%9"*.(347'B.$(%*,'$%4,39"*"9'(%'1"'
34i)"4(3.#'l<%#)4(.*34",,I'(/"'4.()*"'%B'(.,?,'
.49'2*%B",,3%4,I'("$/4%#%73$.#'$%&2#"D3(@I'
(/"'2)*2%,"'%B'),347'("$/4%#%7@I'3493<39).#'
<,:'7*%)2'("$/4%#%73",I'7"49"*I'3493<39).#'
34("##"$().#'$.2.13#3(3",I'"D2"*3"4$"I'.7"'
.49'$)#()*.#'1.$?7*%)49m:
Adoption behaviours – barriers and
ways to overcome them
F,'(/"'+"#9'%B'&-".#(/'&.()*",I'%)*'
)49"*,(.49347'%B'.9%2(3%4'1"/.<3%)*,'
l1%(/'2%,3(3<"'.49'4"7.(3<"m'.,,%$3.("9'
>3(/'/".#(/'("$/4%#%7@')2(.?"'>3##'9"<"#%2'
34',$%2"'.49'4).4$":'C%'9.("I'*",".*$/'34'
(/3,'.*".'/.,'1""4'#3&3("9:'KD(*.2%#.("9'
B*%&'(/"'"D3,(347'#3("*.()*"I'(/"'B%##%>347'
1.**3"*,'(%')2(.?"',/%)#9'1"',""4'.,'.'
,(.*(347'2%34('B%*'B)()*"'>%*?:'F#(/%)7/'
&-".#(/'3,'%B("4'2%,3(3%4"9'%*'2"*$"3<"9'
.,'1"347'.'93,*)2(3<"'("$/4%#%7@'1@'
1%(/'/".#(/$.*"'2*%<39"*,'.49'*"$"3<"*,I'
34("*.$(3%4'%B("4'<.*3",'1"(>""4',(.?"/%#9"*'
7*%)2,:'!"'(/"*"B%*"'2*","4('(/"'9%&34.4('
1.**3"*,'B.$"9'1@'/".#(/$.*"'2*%<39"*,'
l1%(/'.,'3493<39).#,'.49'%*7.43,.(3%4,mI'
.49'(/%,"'B.$"9'1@'2.(3"4(,I'9",23("',%&"'
34"<3(.1#"'%<"*#.2:'!.@,'(%'%<"*$%&"'
(/","'1.**3"*,'.*"'(/"4',"('%)(:
J"<"*.#'Q)%(",'.*"'34$#)9"9'>/3$/'.*"'
.9.2("9'B*%&'(/"',(.?"/%#9"*'*",".*$/'
$%&&3,,3%4'1@'H%9.B%4"1
.
Figure 5 United Theory of Acceptance and Use of Technology
Performance
expectancy
Effort
expectancy
Social
influence
Facilitating
conditions
Behavioural
intention
Behaviour
Age
Experience
Gender
VoluntarinessofuseVoluntariness
Determinants
of use
Moderators of individual use